Modelling the intracellular NF-KB signalling pathway by Pogson, Mark
Modelling the Intracellular NF-nB 
Signalling Pathway 
Mark Pogson 
PhD Thesis 
University of Sheffield 
Department of Computer Science 
December 2006 
Abstract 
NF-nB is a transcription factor which is central to the regulation of genes involved in 
inflammatory and immune responses. Understanding the operation of NF-KB and its asso- 
ciated intracellular signalling pathway is essential in order to control a wide range of chronic 
inflammatory diseases, including asthma and rheumatoid arthritis. Abnormalities in the 
pathway are present in a variety of human cancers and may also affect the pathogenesis of 
Alzheimer's disease. 
Computational modelling of the signalling pathway is necessary to overcome the prac- 
tical limitations of biological experiments and to facilitate a more comprehensive under- 
standing of the system. The thesis begins by outlining existing understanding of the NF-rdB 
signalling pathway, which in conjunction with a review of modelling methods is used to 
inform a different approach to model the pathway, using computational agents to represent 
individual molecules and receptors. The agent-based model is tested with well-understood 
chemical reactions before being used to describe the pathway. This provides a good appre- 
ciation of the system as a whole, offering a detailed description of events at every step in 
the pathway and allowing investigation of stochastic, spatial and structural parameters. 
The modelling process and simulation help to provide a prediction about the role of 
actin filaments of the cytoskeleton in regulating the unstimulated pathway; this is quanti- 
tatively validated by biological experiment. The effect of cell shape on the pathway is also 
investigated. 
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Chapter 1 
Introduction 
1.1 Overview 
Understanding the organisation and dynamics of the components of living systems is a 
fundamental challenge for the life sciences [CW03]. Systems biology seeks to address this 
by explaining biological processes in terms of the interactions of the components of the 
system, from molecules to cells, tissues, organs and organisms [LiuO5, MN04]. 
Central to the operation of living systems are the complex interactions of genes, pro- 
teins and other molecules within the cell that regulate and determine cell behaviour 
[AJL+02, Ne104, LBZ+00]. A primary aim of systems biology is to understand better these 
interactions and consequently the mechanisms that determine the function and behaviour 
of cells. 
Rather than simply catalogue and characterise the physical components of the cell, sys- 
tems biology aims to gain a better understanding of cellular functional activity by collating 
this information in mathematical and computational models based on experimental data. 
This creates the possibility of investigating the cell in far greater detail than is achievable 
by practical experiment alone, providing a means to test and predict possible mechanisms 
that underlie observed behaviours. 
Systems biology is a burgeoning research field which seeks to piece together biological 
understanding into a functional whole [Kit02a, Kit02b, Nob02]. Although system-level 
thinking about biological processes is not in itself new [HN63), only recently has increased 
computing power enabled realistically detailed simulation of large systems. The physiome 
project is a systems biology-based attempt to provide a framework to computationally 
model the human body, from proteins to organs [HRN02, HB03, BasOO]. Molecular in- 
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Figure 1.1: Biological organisation and the physiome. The physiome aims to model 
the organism at various levels, from molecular interactions to organ function. Other areas of 
biological organisation shown are the genome (genes encoded in DNA), transcriptome (messenger 
RNA produced by gene expression), metabolome (metabolites that are present) and proteome 
(proteins produced and where they reside). Above the organism level are population organisation 
and environmental interaction. Many processes are omitted. Figure adapted from Hunter and 
Borg [HB03] and Bassingthwaighte [Bas00]. 
teractions within the cell form an important foundation for such modelling, combining 
proteins into living systems, and tying together gene expression with cell, tissue and organ 
behaviour, as illustrated in Figure 1.1. 
Intracellular signalling pathways are chains of molecular interactions that occur within 
the cell. Signals received from outside the cell are transmitted by these pathways to 
the nucleus to provide specific genetic responses. Signalling pathways are thus vital to the 
regulation of cellular behaviour, and are therefore central to the challenge of understanding 
the organisation and dynamics of the cell. 
In the past, the biochemistry of intracellular signalling pathways has been oversimpli- 
fied [TRRG02]. Signals do not propagate through simple linear chains of proteins, and 
proteins do not work individually but instead assemble fleetingly into molecular machines. 
Furthermore, signalling pathways can interact with each other and with the structure of 
the cell itself. To try to understand all these factors requires suitably detailed modelling 
techniques that account for both spatial and temporal considerations. 
2 
1.2 Background to the NF-iB Signalling Pathway 
Nuclear factor rdB (NF-rcB) is a transcription factor, which in combination with its sig- 
nalling pathway is responsible for regulating genes involved in inflammation and immune 
responses [KG95,131396, CLB98]. The NF-KB signalling pathway is also central to the reg- 
ulation of genes involved in cellular proliferation and apoptosis (cell death). As such it is 
associated with the pathogenesis of many chronic inflammatory diseases, including asthma 
and rheumatoid arthritis [TF01]. Abnormalities in the NF-KB signalling pathway are of- 
ten present in a variety of human cancers and may also be involved in the pathogenesis of 
Alzheimer's disease [YGO1]. 
The intracellular NF-KB signalling pathway is a crucial survival capability present in 
many mammalian cells, with related pathways present in various other species and plants. 
It is part of the innate immune system, which attacks generic classes of foreign molecules, 
as well as facilitating the adaptive immune system for the targeted attack of recognised 
pathogens [O'N05]. The pathway is also involved in responses to physical injury. Its 
modelling is not only important with regard to higher level cell and tissue modelling, but 
is also essential in order to gain a better understanding of how it can be controlled, helping 
to overcome the practical limitations of biological experiments [Bha03b]. 
The intracellular signalling pathway can be triggered by various extra-cellular chemical 
signals as well as by mechanical stress. In its inactive state, NF-AKB exists in the cytoplasm 
bound by its inhibitor protein IKB, as in Figure 1.2. Following `classical' activation of the 
signalling pathway by one or more of a range of extra-cellular stimuli, I, cB is phosphorylated 
(gains a phosphate group) and then ubiquitinated (tagged for destruction), leaving NF-r-B 
free to move (or `translocate') to the nucleus and induce transcription of pro-inflammatory 
genes [YRQ03, YCQ01, CKTC+01, CDQ01]. Activation also causes the expression of IKB, 
thus regulating the signalling pathway through negative feedback [SFL+93]. 
1.3 Background to Modelling the Pathway 
Models are simplified representations of reality that are used to enable or improve under- 
standing; these include linguistic, graphical, experimental, statistical and mathematical 
descriptions. Different modelling methods are useful for different purposes, from a simple 
verbal explanation of events to a quantitative mathematical description and analysis. 
Various modelling approaches have been used to investigate different features of sig- 
nalling pathways [Bha03a, Bha03b]. The choice of modelling approach depends on the type 
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Figure 1.2: Diagram of key interactions in the negative feedback of the NF-KB 
signalling pathway. NF-AKB is held inactive in the cytoplasm by its inhibitor IºdB. Activation 
of the pathway causes I d3-kinase (IKK) to initiate the destruction of IKB, freeing NF-KB to 
translocate to the nucleus and activate appropriate genes. The resulting expression of IKB returns 
the system to its inactive state. 
and detail of the required results, in addition to what information and data are available to 
construct the model; this depends both on the complexity and scope of the pathway as well 
as on the quality and quantity of experimental observations. Modelling is not only useful 
as a means of making sense of observations, but also in raising detailed questions that are 
necessary for the purposes of constructing the model-and are key to the operation of the 
system-but which might otherwise be overlooked [JHR04b, RJHR05]. 
Pathway modelling can be categorised into static and dynamic methods. Static models 
are concerned with the topology of interaction networks, investigating how signals prop- 
agate as a sequence of interactions [Bra03, PHPSO5, BCT+04a]. Such models are useful 
for providing an overview of the behaviour of a pathway rather than investigating specific 
details of its operation. To understand the functional behaviour of pathways, dynamic 
modelling is necessary. 
Previous dynamic pathway modelling has often relied on differential equations derived 
from reaction kinetics to describe chemical concentrations with time, treating the cell 
and its constituents as a continuum [CW03, HLSB02]. Although such models are able to 
provide useful results, they are limited in their scope for a variety of reasons. 
A major concern is that the cell is not a well-mixed bag of chemicals, instead con- 
taining internal structure and low numbers and non-uniform distributions of certain key 
molecules [BT03, BBJ+03]. Ordinary differential equations (ODEs) do not account for this 
inhomogeneity; although temporal modelling is clearly essential in order to understand the 
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dynamics of signalling pathways, it may be insufficient in isolation, and the inclusion of 
spatial information could be equally vital in certain situations due to the nature of pathway 
operation. Although ODE models can be decomposed into separate compartments, such as 
a distinct cytoplasm and nucleus, spatial resolution is still evidently limited [EI04]. Greater 
spatial detail can be incorporated by the use of partial differential equations (PDEs), which 
are functions of both time and space [MSSL02). However, PDE models can be hard to con- 
struct and solve. 
Signalling pathways are composed of sequences of discrete stochastic interactions (EL00}, 
as opposed to the mass-action determinism of a differential equation model. Due to the 
low numbers of certain critical molecules in many pathways, this can be of great signifi- 
cance [ELSS02, ARM98, MA971. The issue has been addressed by the use of stochastic 
differential equations [BT03, BBJ'03, LPB+06], though this does not account for spatial 
concerns. Other modelling techniques, including petri nets [GP98, HKVO1], process al- 
gebras [Mi199, RSS01, CDPT03, CVGO, CGH] and cellular automata [Wei02a, Wei02b], 
have been used to describe signalling pathways, each with their own advantages and dis- 
advantages. 
Models of signalling pathways are strongly informed by insights obtained from biological 
experiments, which themselves are models of the biological systems in question [VAB04]. 
While this is unavoidable, different modelling techniques depend to different degrees on 
experimental data, so comparison of models not only with biological results but also with 
other models can minimise over-reliance on any one source of information. 
Most modelling methods that are used to investigate signalling pathways are abstract 
mathematical constructions with little visual output other than graphical representations of 
results. As models are simply a means of making information more easily understandable, 
a visual representation of the pathway in action is a basic but effective feature of a model, 
requiring not just temporal but also spatial graphing of chemical concentrations to form 
a movie. Although it is very much a secondary requirement, a clearer picture of pathway 
operation is a desirable aspect of any model, providing both a simple means to debug the 
model (since much incorrect behaviour will be immediately obvious) as well as an instantly 
understandable, if not quantifiable, representation of pathway dynamics. 
5 
1.4 Aims of Thesis 
The overall objective of the thesis is to gain an insight into the intracellular NF-ßcß sig- 
nalling pathway. More precisely, the thesis will investigate the pathway by using math- 
ematical and computational modelling, focussing on spatial aspects of the pathway, with 
the following specific aims: 
1. To identify the advantages and disadvantages of different modelling approaches, and 
consequently select the most appropriate for the purposes of modelling the dynamics 
of the NF-nB signalling pathway. The model must incorporate spatial detail and 
include scope for modelling biomechanical stimulation, as these are both vital to the 
operation of the pathway but are neither well understood nor modelled. 
2. To verify the model with existing models and subsequently test it against biological 
results for well understood operation of the pathway. 
3. To use the model to investigate new areas of pathway operation, with the intention 
of forming testable predictions. 
In order to achieve the major modelling aims, the model must fulfil the following re- 
quirements: 
" To be extensible in its formulation, so that extra detail can be added without changing 
the rest of the model. 
" To be sufficiently flexible in its description so that abstractions can be made about 
areas of the pathway that are less fully understood or are of lower importance. 
Although not essential for successfully modelling the pathway, further desirable features 
of the model are: 
" To present a clear and immediately understandable picture of the pathway in oper- 
ation, in the form of a movie. 
" To be composed from detailed mathematical structures that can be investigated by 
techniques developed in computer science. 
" To be in a format that can be used by other modellers, with scope for manipulation 
of the model by biologists. 
6 
1.5 Contributions of Thesis 
The thesis contributes the following: 
1. The main biological features of the NF-03 signalling pathway are outlined and the 
need for its modelling established. 
2. Appropriate modelling methods are identified and previous attempts reviewed, 
3. A new modelling approach is proposed and developed to offer alternative benefits to 
existing work. 
4. The new model is verified at the level of chemical interactions and pathway operation. 
5. The model is used to investigate the pathway in detail, confirming assumptions of 
the pathway and raising a new question about its operation. 
6. The model provides a quantitative prediction about the pathway, which is confirmed 
through biological experiment. 
7. The model is used to investigate physical effects on the pathway. 
8. The model is reviewed and conclusions about modelling the pathway are drawn. 
9. Appropriate directions for future work are suggested. 
1.6 Outline of Thesis 
The thesis is organised as follows: 
Chapter 2: a literature review of the NF-nB pathway. The main details of the oper- 
ation of the NF-rKB pathway are outlined. Different levels of organisation are considered, 
from the construction of proteins to the entire pathway. Details of protein and enzyme 
interactions are described; NF-i B and IKB proteins are considered in further detail; sig- 
nal transduction through surface receptors is noted; nuclear transport is described; the 
cytoskeleton and physical effects are discussed; and gene transcription and translation 
are considered. Biological experimental procedures are summarised and significant recent 
findings reported. 
Chapter 3: a literature review of suitable modelling methods, an analysis of major 
existing models, and an outline for the direction of modelling work in the thesis. The 
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main modelling approaches are described, including reaction kinetics, stochastic differential 
equations, petri nets, process algebra and cellular automata. Major existing models are 
reviewed, including that of Hoffmann et al. [HLSB02]. Agent-based modelling is presented 
in detail, describing its background, finite state machines, X-machines, previous agent- 
based modelling, and how agents can be applied to model the NF-KB signalling pathway. 
Chapter 4: agent-based modelling of chemical interactions. A method for modelling 
chemical interactions is presented and tested against reaction kinetics in appropriate situa- 
tions. The model is then investigated in detail, establishing both its scope and limitations. 
Chapter 5: agent-based modelling of the NF-r,, ß signalling pathway. The chemical 
model is used as a basis for modelling the pathway, with additional details described. 
The model is successfully verified against biological results for pathway dynamics and 
equilibrium. Effects of changing the levels of surface receptors and signalling intermediates 
are investigated in the model, which are in agreement with existing understanding about the 
pathway. NF-KB: InB ratios in the pathway are investigated with the model, which raises a 
question about experimental observations; this provides direction for further investigation 
of the model. 
Chapter 6: modelling physical effects of the pathway. The question about NF-r'BJxB 
ratios in the pathway is investigated further, and a proposed mechanism based on existing 
knowledge is tested in the model. This provides a quantitative prediction about the path- 
way which is confirmed experimentally. The model is then used to investigate the effect of 
different cell shapes on the pathway. 
Chapter 7: conclusions and further work. Conclusions about the pathway and how the 
pathway is modelled are presented. Further work based on these conclusions is suggested. 
Appendix: program code. 
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Chapter 2 
Biology of the NF-rB Signalling 
Pathway 
2.1 Motivation 
Modelling the NF-KB signalling pathway depends strongly upon existing biological knowl- 
edge. If the model is to be successful, it must be informed by biology as far as possible. 
However, it is also important to consider the necessity and relevance of available biological 
information in relation to the level at which the system is to be modelled, the aims of the 
model and its underlying assumptions. 
The model must not simply include all available information but make sense of it as 
straightforwardly as possible. Furthermore, the model must be sufficiently computationally 
inexpensive to permit reasonable execution times. The biology of the signalling pathway 
must therefore be investigated at different levels of detail in order to determine how and 
what the model should describe. 
2.2 Proteins 
2.2.1 Protein Structure 
NF-KB and most other major molecules in the intracellular NF-kB signalling pathway 
are proteins. Protein molecules are constructed from a group of twenty different smaller 
molecules called amino acids [AJL+02, Ne104, LBZ+00]. Every amino acid has the same 
basic backbone, with a `carboxyl' group at one end and an `amino' group at the other, 
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Figure 2.1: Molecular structure diagram of the bonding of two amino acids 
(peptide bonding). The side group (generically denoted by R) determines the identity of 
the amino acid. Proteins are made from long chains of up to thousands of amino acids. Figure 
adapted from Alberts et al. [AJL+02] and Lodish et al. [LBZ4'00]. 
amino acids 
Figure 2.2: Representation of an interaction giving rise to protein conformation. 
A section of a protein molecule is shown, composed of several amino acids that fold and form a 
weak bond that contributes to the overall shape of the protein. Figure adapted from Alberts et 
al. [AJL+02]. 
which act as a plug and socket to bond, as shown in Figure 2.1. Amino acids form long 
chains through covalent peptide bonds to form proteins, which are generally between fifty 
and two thousand amino acids long. 
c is determined Each protein has its own particular three-dimensional structure, whih 
by the sequence of its amino acids; because of the flexibility of an amino acid chain, the 
protein is able to fold and minimise its free energy, interacting with itself through non- 
covalent bonds, as in Figure 2.2. Each of these interactions is very weak, but the net 
effect of several simultaneous non-covalent bonds means the protein is firmly held in a very 
specific shape. 
The principal types of non-covalent bonds that hold such macromolecules in shape are 
Van der Waals attraction, hydrophobic forces, hydrogen bonds, and ionic bonds. Van der 
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Figure 2.3: Multiple weak bonds forming a stable complex. The surface of Protein 
A fits closely with the surface of Protein B, with many weak bonds forming a stable complex. In 
contrast, the surface of Protein A does not fit well with the surface of Protein C, with few weak 
bonds making binding unlikely. Figure adapted from Alberts et al. [A. IL+02] and Loclish et al. 
[LBZ+00]. 
Waals attraction is a short-range attractive force due to the fluctuating dipole moments of 
nuclei. Hydrophobic forces are the result of non-polar hydrophobic molecules distorting the 
usual structure of the surrounding water and causing the water to counteract. this effect by 
pushing the hydrophobic molecules together. Hydrogen bonds occur because of covalently 
bonded hydrogen atoms gaining a slight positive charge due to their bound partner having 
a greater attraction for the shared electron (i. e. the bond is polar); a hydrogen bond forms 
when a similarly slightly negatively charged atom is electrically attracted to the slight 
positive charge of the hydrogen. Lastly, ionic bonds are the attraction of two oppositely 
charged ions. 
2.2.2 Protein Interactions 
The same non-covalent bonds that give proteins their three-dimensional structure (or `con- 
formation') also allow proteins to bind to each other and to other molecules [AJL+02, 
Ne104, LBZ+00]. Any region of a protein surface that can interact with another molecule 
through non-covalent bonds is called a binding site. The shape of two interacting molecules' 
binding sites must be a very close fit to form a stable complex, as displayed in Figure. 2.3. 
Proteins are thus able to interact, and in conjunction with other molecules can act as 
a means of communication inside the cell. Key to protein communications are transcrip- 
tion factors-proteins that bind to DNA, activating the transcription of specific genes to 
messenger RNA (see Section 2.5). 
Molecules in the cell encounter each other very frequently due to their continual random 
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Substrate 1 Substrate 2 Product 
Enzyme 
Figure 2.4: Representation of enzyme action. An enzyme mediates the combination of 
two substrates. The substrate binds to the enzyme, thereby undergoing a conformational change. 
The second substrate then binds to the enzyme, and the resulting product detaches from the 
enzyme. Figure adapted from Nelson (Ne104]. 
thermal movements. When two colliding molecules have poorly matching surfaces, few 
non-covalent bonds are formed between them, and the two dissociate almost immediately. 
Conversely, if two colliding molecules fit well and form many bonds, they can stay together 
for a very long time, remaining bound until they are separated by either thermal motion 
or a molecular signal. Dimers are molecules formed from the non-covalent combination of 
two similar or identical molecules (forming hetero- and homodimers respectively), which 
exist together indefinitely. 
2.2.3 Enzymes 
Large proteins generally consist of several distinct domains-structural subunits whose 
conformations are essentially independent of each other [AJL+02, Ne104, LBZ+00]. Large 
proteins with many domains are able to perform elaborate functions. 
Enzymes are large proteins that are of vital significance to cellular activity. Enzymes 
catalyse chemical reactions in the cell by holding molecules (substrates) in such a way that 
it lowers the energy required for them to interact, as in Figure 2.4. Enzymes are not used 
up or altered in the process, and work by causing conformational changes in the substrates. 
Enzymes can be categorised according to the effect they have on their particular sub- 
strates. Kinases and phosphatases are two types of enzyme that are crucial to regulating 
the activity of many cellular proteins, including those in the NF-KB pathway. 
Kinases catalyse the transfer a phosphate group (a compound of phosphorous and 
oxygen) from an ATP (adenosine triphosphate) molecule to a particular region of a protein 
[Wil88]. The process is called phosphorylation, and to occur, the target protein must 
possess a specific binding site called a phosphorylation site. The addition of a phosphate 
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group to the protein can cause major conformational changes in the protein due to the 
double negative charge of the phosphate group. This affects the binding sites on the 
protein, and can also form part of a new binding site, hence changing the behaviour of the 
protein. 
Phosphate groups are attached to one another by high-energy bonds, which in the case 
of ATP are formed by the metabolism. The release of one of the three phosphate groups 
in ATP is an energetically favourable reaction; ATP thus acts as an energy store that 
allows the execution of otherwise energetically unfavourable or impossible reactions in an 
organism. 
Phosphatases perform the opposite function to kinases: they catalyse the removal of 
a phosphate group from a protein, returning the protein to its pre-phosphorylated state. 
Kinases and phosphatases can therefore act as `on' and `off' switches for actions of certain 
proteins. 
2.2.4 Nuclear Factor iB and its Inhibitor 
NF-KB transcription factors are hetero- or homodimers formed from a family of proteins 
composed of two subfamilies: those containing DNA activation domains, of which there 
are three proteins, and those lacking, of which there are two proteins (CCDQ991. Each 
dimer combination activates its own characteristic set of genes. The prototypical NF-rKB 
is a heterodimer of p65-RELA (containing an activation domain) and p50 (lacking an 
activation domain). Most NF-KB dimers contain DNA activation domains, although there 
exist those without. 
In the inactive state of the signalling pathway, NF-, B is bound by its inhibitor molecule 
IKB, preventing its association with DNA and causing its localisation to the cytoplasm by 
masking the relevant binding sites on its surface. There are at least seven IKB isoforms 
(isoforms are molecules with the same or similar functions but the product of different 
genes), though the activity of most NF-KB in mammals is largely controlled by just three, 
namely IKBa, -, ß, and -e, of which Ir. Ba is the most critical [LPB+04]. 
NF-KB is so named because the family of proteins were first identified through their 
interaction with enhancers (regulators of DNA transcription) of the tc light chain (a par- 
ticular sequence of amino acids) in B cells (a type of lymphocyte, or white blood cell, that 
makes antibodies) [SB86]. 
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2.3 Signal Transduction 
Signal transduction is the conversion of a signal from one physical form to another. In 
the cell, this is the conversion of an extracellular signal into an intracellular signal without 
physical flow through the plasma membrane, and it results in specific cellular responses 
[AJL+02, LBZ+00, HP96, Han97]. 
2.3.1 Cell Surface Receptors 
There are three main signal transduction cell surface receptors in the NF-kB pathway: toll- 
like receptors (in particular toll interleukin-1 receptors, or TIRs), protein tyrosine kinasc 
receptors, and adhesion receptors, each of which transmits different forms of extracellular 
signal into the cell, as shown in Figure 2.5. 
TIIts are activated by cytokine signalling molecules interleukin-1 (IL-1), which are 
produced by cells of the innate immune system. Upon these soluble agonists binding to 
the extracellular domain of a TIR, conformational changes are induced in the intracellular 
domain of the receptor, thus relaying the signal into the cell by making it possible for 
certain receptor complex component proteins to bind. The receptors continually move 
around the plasma membrane. 
2.3.2 Cytoplasmic Pathway 
IL-1 activation is a main channel of the NF-KB pathway [YRQ03, YCQ01, CKTC+01, 
CDQ011. Following activation of an IL-1 receptor, scaffold proteins MyD88 and TRAF6 
bind to the inner surface of the receptor. These adaptor proteins then bind IRAK 1/2/3/4 
kinases and phosphatases together in a functional complex. The resulting intermediate 
interactions lead to the phosphorylation and activation of IKB kinase (IKK). 
Active IKK in turn phosphorylates IrcB, causing small ubiquitin molecules to covalently 
bind to the IKB. This results in the destruction of IKB by a proteasome-a large cylindrical 
protein that degrades ubiquitin-tagged proteins in an ATP-dependent process. The newly 
released NF-KB is then free to translocate to the nucleus and initiate gene transcription. 
Although structurally unrelated, protein tyrosine kinase receptors operate in much the 
same way as TIRs in response to their relevant cytokines, although the resulting cytoplas- 
mic protein interactions that lead to the activation of NF-KB are somewhat different and 
not discussed here. Adhesion receptors activate in response to cell adhesion and mechanical 
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Figure 2.5: Signal transduction in the NF-r. B pathway. The pathway is triggered by 
either cytokine activation of the TIIts or tyrosine kinase receptors, or by cell adhesion or mechan- 
ical stimulation of the adhesion receptors. Activation of Tlßs results in the linear pathway on the 
left of the diagram. The other receptors trigger complex cross-signalling networks involving many 
proteins, some of which are included in the diagram, though most are unlabelled for simplicity. 
The target of the pathway is the activation of NF-nB, which translocates to the nucleus and 
activates appropriate genes. Figure adapted from Qwarnstrom [Qwa03]. 
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stress; the resulting pathway is less well understood, although nonetheless vital to the sys- 
tem. The cytoskeleton (a system of protein filaments inside the cytoplasm giving the cell 
its shape and ability to move) is able to bind proteins, and changes in its conformation may 
affect protein binding; this may be vital to the activation of the pathway by mechanical 
stress (see Section 2.4). 
2.3.3 Nuclear Transport 
NF-nB is transported into the nucleus by nuclear import receptors [AJL+02, LBZ+00]. 
While very small molecules can freely diffuse through the nuclear pore complexes on the 
nuclear membrane, and medium-sized molecules can enter directly through active nuclear 
pores, large molecules like NF-kB require nuclear import receptor molecules to bind them 
as cargo to transfer them through nuclear pores (see Figure 2.6). Nuclear import recep- 
tors exist in the cytoplasm awaiting molecules to transport. When NF-AKB is separated 
from IKB, a particular binding site called its nuclear localisation signal is exposed; this 
is recognised and bound by an appropriate nuclear import receptor. The nuclear import 
receptor then binds to the nucleoporins that make up the nuclear pore complex, and a 
GTP-dependent process (GTP is similar to ATP) `walks' the NF-KB into the nucleus. 
Free IKB molecules can be imported into the nucleus in the same manner (their nuclear 
localisation signal is mutually masked by NF-KB). Nuclear export of the molecules works 
similarly, but requires nuclear exporting receptors (which exist in the nucleus) instead 
of nuclear importing receptors. Although nuclear pores allow passage through in both 
directions, it is not properly understood how congestion and collisions are avoided. The 
energy for the GTP-dependent import and export process comes from Ran, a molecule that 
exists in two different states according to whether GTP or GDP is bound, thus coordinating 
import and export (see Figure 2.7). 
2.3.4 Pathways, Networks and Modules 
The NF-rkB signalling pathway is sometimes also referred to as the NF-KB signalling mod- 
ule [HLSB02], since it can be conceptualised as a modular entity in a larger network of 
interactions [YYGK02]; the NF-nB signalling pathway can interact with many other path- 
ways such as the MAP kinase pathway [Moy05]. However, usage of the terms `network' 
and `module' is often contextually dependent. The term `pathway' appropriately suggests 
a definite input, a chain of interactions, and a definite output, and is a widely understood 
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Figure 2.6: NF-nB import through a nuclear pore complex. While small molecules can 
move freely through the nuclear pore, and medium sized molecules require the complex to actively 
transport them through, large molecules such as NF-t B require a nuclear receptor molecule to 
move them through the complex in a GTP-dependent process. Figure adapted from Alberts et 
al. [AJL+02] and Lodish et al. [LBZ+00]. 
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Figure 2.7: Representation of the involvement of Ran in nuclear transport. Energy 
for the transport of the protein cargo comes from the release of a phosphate group (P; ) from GTI', 
which is mediated by a further reaction, which is not shown. Figure adapted from Alberts et al. 
[AJL+02]. 
description of the system. 
2.4 The Cytoskeleton 
The cytoskeleton is a complex structure with many functions which exists inside the cell 
[AJL+02]. It provides spatial organisation within cells and a means of mechanical inter- 
action with their environments; it allows cells to change shape and move, and facilitates 
the rearrangement of internal components of the cell during growth, division and changing 
circumstances. Although not all aspects of the cytoskeleton have a direct relation to the 
operation of the NF-KB pathway, certain features of the cytoskeleton have a crucial impact 
on particular mechanisms in the pathway, and must be understood in order to explain 
specific behaviours of the pathway. The varied functions of the cytoskeleton depend on the 
behaviour of its different components, the main types of which are discussed below. 
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Figure 2.8: Diagram of main components of the cytoskeleton and their general 
distribution in a typical cell. The cell is an interphase cell, i. e. it is not undergoing mitosis 
(cell division). Figure adapted from Alberts et al. [AJL+021. 
2.4.1 Major Types of Protein Filaments that form the Cytoskele- 
ton 
The cytoskeleton is composed of three main types of protein filaments---actin filaments, 
microtubules and intermediate filaments-which are in part organised by the centrosomc, 
as shown in Figure 2.8. 
Actin Filaments 
Actin filaments are flexible protein polymers with a diameter of 5-9nm [AJ1,102]. They 
exist throughout the cytoplasm, especially near the plasma membrane. The filaments 
determine cell shape, and are necessary for cell motility; the filaments can form projections 
from the cell surface to move the cell around. Actin filaments also line the inner face of the 
nuclear envelope, providing protection for DNA. Actin nucleation (where sufficient, numbers 
of monomers are bound such that polymer formation becomes more rapid) often occurs at, 
the cell cortex (the region near the plasma membrane), and is often regulated by external 
signals. Each monomer (or `G-actin' (globular); `F-actin' is the polymer (filamentous)) 
has a binding site for one ATP or ADP molecule, permitting a form of movement, of the 
filament, the description of which is unnecessary here. 
Although actin can attach to proteins embedded in the plasma membrane, most, at- 
tachments are through other proteins (such as talin), which attach to proteins embedded 
in the membrane. 
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Microtubules 
Microtubules are long hollow cylinders with an outer diameter of 25nm made from tubulin 
proteins cY-tubulin and ß-tubulin. The filaments are much more rigid than actin. One end 
of each microtubule is generally attached to the centrosome, and the structure determines 
the positions of organelles and directs protein transport. The filaments are arranged in a 
star-like array emanating from the centrosome in an interphase cell, but quickly rearrange 
into a `bipolar mitotic spindle' during cell division. Like actin, each monomer has a binding 
site for one GTP or GDP molecule, permitting similar movement. Unlike actin, tubulin 
nucleation generally occurs at the centrosome. 
Intermediate Filaments 
Intermediate filaments are rope-like fibres, with a diameter of about 10nm, which attach to 
different parts of the cytoskeleton. The are made from a large family of different proteins, 
and provide mechanical strength. 
2.4.2 Cytoskeletal Organisation, Operation and Dynamics 
The centrosome exists at the centre of the cell (next to the nucleus), and `organises' the 
dynamics of microtubules [AJL+02]; the details of its operation are not required here. 
Accessory proteins link filaments to each other and to other cell components. They are 
essential for the controlled assembly of cytoskeletal filaments in particular locations; the 
accessory proteins bind to filaments to determine the sites of assembly of new filaments. 
Motor proteins are a class of accessory protein that move organelles along filaments or even 
move filaments themselves. 
Large-scale cytoskeletal structures can alter depending on requirements, with time 
scales of change ranging from under a minute to the life of the cell. Individual macro- 
molecules of the structure constantly change; their relatively small size allows rapid diffu- 
sion. All filaments are formed from helical assemblies of monomers, and their non-covalent 
bonding allows rapid assembly and disassembly; large number of bonds arc therefore re- 
quired for strength. Linear single-stranded protofilaments combine laterally. 
2.4.3 Cell Communication 
Adherens junctions are where actin binds to the cell membrane [AJL+02, LBZ+00]. Actin 
filaments close to the membrane are either linked to other cells or the extra cellular matrix 
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(a `focal adhesion') through integral membrane proteins (namely `cadherins' or `integrins' 
respectively). Adherens have a complicated structure, with multiple different types, de- 
pending on the cell. Their complicated structure permits dynamic control of mechanical 
properties of different regions of the cell, which affects cellular function. The receptors 
also relay information about external mechanical and chemical properties to the inside 
of the cell. Focal adhesions bind to proteins of the extra cellular matrix (ECM), such 
as fibronectin, laminin and collagen. Some proteins in focal adhesions have a signalling 
rather than mechanical or structural role (such as focal adhesion kinase (FAK)). Focal 
adhesions receive multiple inputs from the extra cellular matrix-mechanical tension and 
phosphorylation signals-and integrate them, producing multiple outputs. 
Integrins are a large and diverse family of transmembrane proteins, which bind as het- 
erodimers, each having a different affinity for ECM proteins. The inner surface of an 
integrin binds with a complex cluster of cytoskeletal and accessory proteins; some of these 
proteins (including a-actinin, viculin and tensin) can also associate with cadherins, while 
others (such as talin) only associate with integrins. Actin filaments insert into a protein 
plaque [Bra0l]. The binding of integrins to ECM proteins promotes their aggregation in 
the plasma membrane and their interaction with the cytoskeleton and signalling molecules 
[WMG99]. This leads to the assembly of focal adhesions and activation of signalling path- 
ways which regulate gene expression. 
Rho is a small GTP-containing protein that is essential to form focal adhesions. It 
has a central role in controlling many actin-membrane associations. Rho belongs to a 
family of over 40 GTP-binding proteins (G proteins) called the Ras superfamily, which 
relay intracellular signals and regulate many processes in cells. Rho is `active' when bound 
to GTP, and `inactive' when bound to GDP, with the addition and loss of the phosphate 
group catalysed by other proteins. 
2.5 Gene Transcription and Translation 
Once NF-nB is free in the nucleus, it is able to activate the transcription of appropriate 
genes, resulting in particular cell responses [AJL+02, LBZ+001. Every gene has a region 
called a promoter site, which is a sequence in the DNA indicating where transcription of 
that gene should begin. The genes that NF-kB activates are those whose promoter sites 
can interact with the relevant binding sites of the particular NF-rcB dimer. 
Following the binding of NF-KB to a promoter site, many other proteins bind around it, 
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Figure 2.9: Catalysis of transcription of DNA into RNA by RNA polymerase. 
(a) Following gene activation, RNA polymerase binds to DNA. (b) DNA separates its strands. 
(c) The first RNA monomer unit is paired to the starting base of the DNA (only one DNA strand 
need be copied). (d) RNA polymerase moves along the DNA strand, continuing the process until 
the transcription is complete. Figure adapted from Alberts et al. [AJL+02]. 
reinforcing the connection with the DNA and encouraging the binding of RNA polymerase. 
RNA polymerase is an enzyme that catalyses the synthesis of RNA on the DNA template, 
as shown in Figure 2.9. Once RNA polymerase has bound, the section of DNA uncoils its 
double helix and the RNA polymerase moves along its length, causing the transcription of 
its information into RNA. The movement is jerky (or `stepwise') and several proteins are 
involved to decrease the likelihood that the RNA polymerase dissociates before it reaches 
the end of the gene. 
NF-, cB activates the transcription of thousands of genes, although the genes of most 
interest to modelling the negative feedback of the system are the IKB-encoding genes, of 
which there is one gene for each IKB isoform. 
Having transcribed a gene, the newly formed RNA molecule leaves the DNA and exits 
the nucleus into the cytoplasm. Here it associates with a ribosome, which catalyses the 
synthesis of the encoded protein. The process, known as translation, is complex and 
requires the interaction of many amino acids. 
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2.6 Experimental Procedures 
The NF-KB pathway has been subject to extensive biological experimentation in recent 
years. Much work has involved experimenting on several thousand cells at a time, which 
must be killed in order for results to be obtained. The results arc for the entire group of 
cells, effectively averaging the behaviour of all cells. Due to the large differences in cell 
behaviours, this averaging does not necessarily provide a reasonable description of what 
is actually occurring in any cell. More recently, single-cell analysis of live cells has been 
possible using confocal microscopy. This allows observation of the varied behaviours of 
individual live cells [YRQ03, YCQ01, CKTC+01, CDQ01]. 
Confocal microscopy is able to observe a thin layer of a cell at a time, which means that 
the nucleus and cytoplasm can be clearly distinguished. To be observed, molecules must 
possess fluorescent tags (which do not affect the behaviour of the molecule), so molecules 
occurring naturally in the cell cannot actually be observed. Instead, artificial DNA, which 
is encoded to produce (or `express') particular molecules with fluorescent tags, is placed 
(or `transfected') inside the cytoplasm, thus introducing observable molecules into the cell. 
The cell can then be experimented on, and the movement of the newly expressed 
molecules can be followed. Individual molecules cannot be identified; rather it is net move- 
ment of molecules that is observed. To observe the molecules, focused laser beams induce 
the fluorescence of molecules in a slice of the cell approximately one micron thick. Human 
fibroblast cells (found in connective tissue) are commonly used due to their resilience to the 
experimental conditions and procedures, though similar results should be obtained with 
many other cell types. An example of the images obtained is shown in Figure 2.10. 
Large numbers of fluorescent molecules are necessary to be observable by confocal 
microscopy-far greater than endogenous levels-though if too many are introduced to 
the cell, the behaviour of the cell is altered [CCDQ99]. Care must therefore be taken to 
ensure optimal transfection levels. Another problem is that not many different colours of 
fluorescent tags exist, so only a few types of molecule can be observed at the same time. 
Furthermore, because only one slice of the cell is viewed, the behaviour of the cell must 
be assumed to be uniform in order to draw conclusions about its overall behaviour. It 
is difficult to observe several slices of the cell to overcome this, though the issue can be 
minimised by repeated tests and comparisons. To give a true representation of events, the 
entire cell should be observed layer-by-layer, rather than relying on a single layer as being 
representative of the whole. 
NF-r-B is generally observed by tagging p65-RELA, which is the active part of most 
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Figure 2.10: Confocal microscope images of a cell's NF-KB molecules following 
IL-1 stimulation. The number in the corner of each image shows the time in minutes following 
IL-1 stimulation. The dark patch in the centre of the cell at zero minutes is the nucleus, which 
is visibly free of NF-KB. As time progresses, the concentration of NF-rB in the nucleus increases 
markedly. The intensity of the fluorescence can be used to plot the concentration of NF-KB 
with time in each compartment (see Figure 2.11). Scale bar 10/im. Figure from Carlotti et al. 
[CDQO1]. 
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NF-KB dimers; while this is not exactly the same as tagging every NF-icB molecule, it 
is a good guide. In this section of the thesis, the term NF-kB is used to refer to the 
tagged RELA subunit. Similarly, I, dB is used to refer to the I, Bce isoform tagged in many 
experiments. 
2.7 Experimental Observations 
Studying the dynamics of nuclear transport of NF-KB following stimulation of the cell 
with IL-1 shows approximately a 30-fold increase in nuclear levels and 20% decrease in 
cytoplasmic levels [CCDQ99]. The nuclear to cytoplasmic ratio of NF-KB concentration is 
around 1: 10 in the unstimulated cell and around 4: 1 in its maximally stimulated state. 
The kinetics of nuclear transport depends on the IL-1 dose and the transfection levels 
of NF-icB (the latter being a consequence of the experimental method). The rate of nuclear 
uptake of NF-rkB is saturable; this occurs at less than saturating doses of IL-1, suggesting 
the rate-limiting step lies in the signal transduction cascade. 
The estimated maximum rate of flow of NF-,. B into the nucleus, which is calculated to 
have volume of 100µm3, is around 40 to 60molecules per second [CCDQ99]. Rather than 
plateau at this maximum when the NF-nB concentration is high, the nuclear import rate 
peaks and subsequently declines with increasing fluorescent NF-icB expression levels; the 
cell's response to IL-1 is biphasic, with a decline in the nuclear import rate of NF-icB at 
expression levels above 3 to 4 times endogenous (naturally occurring) levels. This correlates 
with the anti-apoptotic function of NF-KB, which is more prominent at low expression 
levels, and provides successively less protection at higher levels. In cells overexpressing 
NF-KB 30-fold, the minimum nuclear concentration of NF-KB is comparable to endogenous 
levels of nuclear NF-KB in a stimulated cell, which could explain the impairment of nuclear 
localisation in overly transfected cells. 
Nuclear import is a continuous process, and does not display rapid rate changes. Fol- 
lowing the nuclear concentration of NF-KB peaking, it takes long time for the cell to return 
to its basal state (more than 90 minutes), so the signal transduction pathway can remain 
activated for prolonged periods. 
The anti-apoptotic function of NF-kB depends on its induction of protective genes. 
Since low levels of NF-KB have an anti-apoptotic effect, anti-apoptosis might be determined 
by free IkB levels. However, the loss of anti-apoptotic function at high expression levels 
is probably a consequence of the activation of different a set of genes (possibly those with 
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weaker NF-, B binding sites) as opposed to a drop in free IKB levels, since IKB is efficiently 
induced. 
Using the nuclear export inhibitor leptomycin B (LMB), it is shown that shuttling 
between the nucleus and cytoplasm of NF-KB and IKB occurs even in unstimulated cells 
[CDQ01]. The shuttling is suggested to be a consequence of the cytoplasmic dissociation of 
the NF-r. B-IKB complex rather than its direct nuclear import or degradation and resynthe- 
sis of IKB. Determination of the kinetics of nuclear entry shows that import of IrKB occurs 
more rapidly than import of NF-KB. The rate of LMB-induced nuclear accumulation of 
NF-icB is lower than the rate of import in cells containing physiological levels of NF-rKB 
following activation by IL-1, suggesting that the shuttling is not simply a consequence of 
high levels of NF-KB in the experiment. 
It is deduced that around 17% of NF-KB is not bound to Iid3a in a resting cell. It 
is suggested that non-saturated interaction of NF-KB with the inhibitor may enhance the 
specificity of action of IKB proteins on different NF-KB dimers and allow additional modes 
of regulation of IKB function. Levels of both NF-icB and IKB proteins are specific to cell 
type and developmental stage. 
Whereas LMB-induced nuclear localisation of NF-KB is almost linear during the first 
60 minutes of treatment and displays minimal time lag, the IL-1-induced response has 
a distinct lag (as expected for the pathway to react) and reaches plateau. Cells treated 
with both IL-1 and LMB also plateau, but at a level six-fold above the initial cytoplasmic 
concentration, which is more than that found by adding the effect for LMB and IL-1 alone. 
This level of nuclear translocation depletes approximately 70% of cytoplasmic NF-KB. The 
time lag in NF-KB nuclear uptake following IL-1 stimulation increases at higher transfection 
levels. 
The maximum absolute nuclear translocation rate in response to LMB is higher than 
that in IL-1-stimulated cells, again indicating that the limiting factor for nuclear localisa- 
tion in the latter is not the import mechanism. Since the nuclear import effects of IL-1 
plus LMB are greater than additive, it would appear that increased nuclear to cytoplas- 
mic transport of NF-, B occurs following IL-1 stimulation than in a resting cell. However, 
blocking the nuclear export pathway does not significantly reduce the saturability of IL-i- 
induced nuclear translocation of NF-nB at high expression levels, suggesting the restriction 
lies in the pathway. 
Single-cell analysis shows the diversity of responses of cells. For example, some cells 
are fully stimulated at the lowest IL-1 dose, whilst others are only partially stimulated 
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Figure 2.11: Graph of fluorescent intensity of molecules against time for a single 
cell following stimulation by IL-1. The fluorescent intensity is proportional to the con- 
centration of the molecules. FRET refers to bound RELA and IKB. The fluorescent tags of the 
molecules are chosen such that the frequency of light emitted by B. ELA stimulates any nearby Ir. B 
to fluoresce. RELA is then excited by a laser of a particular frequency, and any IKB fluorescence 
detected is recorded as FRET, although the number of FRET recorded will be slightly higher 
than the number of bound RELA and IKB since the required proximity of an IºKB molecule to a 
RELA molecule to exhibit FRET is slightly greater than the distance between bound molecules. 
The freeing of cytoplasmic RELA and its subsequent nuclear translocation is clear in the graph. 
Data from Yang [Yan03]. 
by the highest dose. Experimental results vary greatly between different cells, but general 
patterns of behaviour are often similar. An example of the typical results for an experiment 
on a single cell following stimulation by IL-1 is shown in Figure 2.11. 
Despite the level of understanding obtained from experiment, the limitations of exper- 
imental procedures show the need for a model to allow any number of types of molecule to 
be observed under any conditions. The model must be verified against the large amounts 
of existing biological data on the pathway. 
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Chapter 3 
Modelling the NF-rB Signalling 
Pathway 
3.1 Key Features to Model 
The purpose of the model is to determine and understand the key elements of the pathway- 
not to replicate the system in its entirety and thereby create something equally incomprehensible- 
so choosing the appropriate level of complexity for the model is essential if it is to be 
successful. 
Many details of the signalling pathway are of fundamental importance to its behaviour 
but need not be modelled directly. Indeed, if the model is to succeed in reducing the 
system to its crucial elements, it is necessary that many such details are not modelled 
directly but instead accounted for at a higher level. For example, the peptide bonding of 
amino acids to form proteins underpins the activity of the entire pathway, though it is the 
actual behaviour of the proteins that is of interest to the model, and not the details of their 
formation. Similarly, while NF-KB are dimers, they act as single entities whose behaviour 
can be explained by their components, and the model need generally only consider the 
behaviour of the whole NF-kB. 
The model must of course deal with the interaction of molecules in the pathway. While 
details of binding sites, non-covalent forces and molecular orientation are beyond the scope 
of the model, they must be accounted for (or `abstracted away') by the rules and calcula- 
tions of interactions (see Chapter 4). Details may also have to be abstracted away due to 
computational limitations. 
A more obvious issue for the model is to decide what molecules are important to the 
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behaviour of the system. For example, although there are at least seven different IKB types, 
it may not be necessary to model them all, at least initially. While biological knowledge 
provides clues as to which are most important, it is part of the model's purpose to help 
determine this, as well as what the role of each molecule is. 
There is a great deal of biological knowledge of certain aspects of the system, though 
much of this is too detailed for the model. Conversely, many details of the system are not 
understood or perhaps not even known, and abstraction of these details is imposed on the 
model rather than chosen. This issue is central to most models, though it is particularly 
apparent here due to the interdependence of many aspects of the system and the lack of 
quantitative knowledge of key processes. 
It is impossible to fully model such a complex and wide-ranging system as the NF-KB 
pathway. It is important, however, to account for the limitations of the model; while it 
may not be possible to explicitly model certain aspects of the pathway, their effects on the 
system often cannot simply be ignored. It can be difficult to determine the significance 
of many components of the system, and features that appear not to be directly related to 
the concerns of the model may in fact be vital elements. There may, of course, also be 
important aspects of the pathway that are not even known. However, these issues must be 
overcome or else the model would have to include all the activities of the cell (or even the 
entire organism) in an effort to deal with the complexities and coordinated response of the 
system. 
3.2 Modelling Methods 
Since reaction kinetics is by far the most widely used and accepted approach to model the 
dynamics of the NF-rcB signalling pathway (as well as biochemical dynamics in general), 
this is considered first. Various methods besides reaction kinetics have also been proposed 
to model biological signalling pathways [BCT+04a, HS98]. Some provide a quantitative 
description of pathway dynamics similar to reaction kinetics, while others offer a qualita- 
tive description of the topological structure and steady-state properties of pathways. A 
qualitative model can produce useful results, and is less hindered by the lack of reliable 
data for kinetic interactions, though such a model would be inappropriate for the aims 
of understanding the activation and dynamics of the NF-KB pathway. Other modelling 
methods are evaluated with respect to pathway modelling. 
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3.2.1 Reaction Kinetics 
Reaction kinetics is concerned with the rate at which chemical reactions occur [DS92, PS95]. 
It is able to mathematically describe reaction rates by combining experimental data with 
theoretical equations. It is a well-understood and accurate model of chemical reactions that 
involve sufficiently large numbers of molecules that the fluctuations of individual stochastic 
chance molecular interactions may be assumed to be unnoticeable in the overall process; 
hence the overall chemical reactions are effectively deterministic. 
The `order' of a reaction refers to the number of molecules engaged in the reaction. 
A first order reaction is a spontaneous change of a molecule A into another molecule ß 
without having to interact with any other molecules. Or, in chemical notation, with `rate 
constant' k: 
A4B (3.1) 
Experimental observation shows that the reaction proceeds at a rate proportional to 
the concentration of the original molecule, with k the proportionality constant. Expressing 
Equation 3.1 mathematically, using lower-case letters to denote concentration: 
da(t) 
_ -ka(t) (3.2) dt 
d 
(t) 
= ka(t) _ 
da( t) (3.3) 
It is thus simple to describe the concentration of the chemicals with time by integrating 
Equation 3.2. An analytical solution is straightforward here, but in more complicated cases 
a numerical solution is often required. 
In reality, there is always a reverse reaction, even if negligibly small, since one-way reac- 
tions are not thermodynamically possible. Consequently, with 1 the reverse rate constant, 
Equations 3.1,3.2 and 3.3 become: 
A=B (3.4) 
1 
da(t) 
_ -ka(t) + lb(t) (3.5) dt 
dý t) = ka(t) - lb(t) 
da(t) t) (3.6) 
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Of greater interest in many circumstances is the reaction of two chemicals to form a 
third compound substance in a second order reaction: 
k 
A+B (3.7) 
The rate at which the reaction proceeds is proportional to both a and b in the forward 
direction, and to c in the reverse (since the reverse reaction is first order): 
da(t) 
_ -ka(t)b(t) + lc(t) dt 
(3.8) 
db(t) 
_ -ka(t)b(t) + lc(t) = 
da(t) (3,9) 
dt dt 
dritt) 
= ka(t)b(t) - lc(t) _ -ddt) (3.10) 
When modelling chemical systems, if a chemical can react with multiple chemicals then 
the appropriate terms for each possible reaction can simply be added to the chemical's 
rate equation, just as forward and reverse reaction terms are added together. Due to 
the interdependence of all the concentrations, however, large systems can quickly become 
intractable, and care must be taken when obtaining solutions. 
It is possible to model the dynamics of many chemical systems by using these equa- 
tions in combination with the experimentally determined rate constants of each reaction. 
However, biological systems usually also depend upon enzyme activity. Enzyme-mediated 
reactions are of the form: 
km 
S+ E; --± C;:: ± P+E in 
(3.11) 
where S is the substrate, E the enzyme, C the complex, and P the product. 
Due to the nature of enzyme interactions, n will be negligible (see Section 2.2.3). In 
Equation 3.11 it is assumed that only one substrate is present, yet this assumption may 
seem unrealistic since most enzyme interactions involve two substrates. However, in most 
cases one of the substrates will be present in excess, so will not influence the reaction rate 
of the process. In the unusual case where both substrates are present in similar quantities, 
Equation 3.11 does not hold. 
The dynamics of the process under the appropriate conditions, with E and C present 
in very much lower concentration than S, are: 
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ds(t) 
= _ke(t)s(t) + lc(t) (3.12) dt 
de(t) 
_ -ke(t)s(t) + lc(t) + mc(t) - np(t)e(t) (3.13) dt 
dc(t) 
= ke(t)s(t) - lc(t) - mc(t) + np(t)e(t) _ -dritt) (3.14) 
dp(t) 
_ dt mc(t) - np(t)e(t) 
(3.15) 
By combining these basic reaction rate equations, many biological pathways have been 
modelled, including the intracellular NF-iB pathway. Due to the large number of chemicals 
involved, it is likely for there to be several interdependent equations to be solved. Con- 
sequently, small changes in parameters can completely upset the entire model. Although 
procedures exist to enable variations of parameters in systems involving large numbers of 
parameters, it is a problem inherent to the model [MK98]. 
Because of the different volumes of the nucleus and cytoplasm, movement of chemicals 
between them affects their concentration, since it is molecules that move, not the concen- 
tration. Care must be taken to account for this, requiring affected terms to be multiplied 
by the relative volumes of the compartments. 
Nuclear membrane transport of a chemical is generally treated as a first order reaction 
of a molecule simply `changing' from being in one compartment to the other; due to the 
nature of the model, there is no actual spatial concept of a compartment. This simple 
diffusion clearly does not closely resemble the complicated biology of the situation. The 
transport of molecules across the nuclear membrane is a crucial step in the signalling 
pathway, and more detailed modelling of the process would be desirable. 
Owing to the largely unknown nature of the underlying regulatory processes involved 
in transcription and translation, rate equations to describe them are difficult to formulate, 
and are largely based on guesswork. While this would be true for any modelling method 
used to describe transcription and translation, the strong interdependence of equations in 
a reaction kinetics model means the unavoidable inaccuracy is of critical significance to 
the entire model. Moreover, because of the low numbers of molecules involved in certain 
parts of the processes, such as having just one gene for the transcription of each protein, 
reaction kinetics is not necessarily an appropriate model to apply to the situation anyway. 
The difficulty of incorporating the time delays of the processes into differential equations 
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is another problem with the method. 
While reaction kinetics can provide a very accurate description of many chemical 
processes-including some parts of the intracellular NF-KB signalling pathway-its use 
to describe the entire intracellular NF-nB signalling pathway is not always appropriate, 
dependent on the purpose of the model. A different modelling method is certainly required 
if mechanical stimulation of the pathway is to be given proper consideration. A more suit- 
able model may include reaction kinetics for some parts of the pathway, but it would be 
used in conjunction with a different approach for key sections. 
3.2.2 Stochastic Simulation 
Stochastic differential equations are able to describe systems where the number of particles 
involved is so small that microscopic fluctuations can produce macroscopic effects, as with 
genetic and enzymatic reactions in living cells [BT03, BBJ+03]. Simulation of the equations 
requires a variable time step in which only one reaction occurs. Recent work has developed 
a method that allows more than one reaction to occur at each time step, known as the 
, r-leap method. This eases computation, but introduces some errors (though these are 
controllable). The method clearly overcomes the issue of treating discrete molecules as a 
continuum in standard reaction kinetics equations, but is still unable to explicitly account 
for spatial issues. The technique partially overcomes problems of ODE descriptions but 
does not provide a new approach to modelling. 
3.2.3 Petri Nets 
Petri nets are a mathematical formalism developed in computer science [GP98]. Originally 
created to model concurrent systems, they are well suited to deal with biological processes, 
and have recently been used for such purposes. They have a standard graphical representa- 
tion that is simple to interpret and to use to define models. Models can be implemented by 
specific software rather than a lower-level programming language, making them relatively 
easy to create and modify. 
Different forms of Petri net exist, though stochastic Petri nets are of particular interest 
to modelling intracellular signalling pathways. The mathematics of stochastic Petri nets 
can be used to describe the details of molecular interactions, specifically: the individual 
molecule, the molecular species, the number of molecules, the reaction, the reactant, the 
chemical product, the rate of reaction, the possibility of a reaction, and the occurrence 
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of a reaction. This provides a clear description of signalling events, allowing quantitative 
modelling of the dynamics of biochemical pathways. 
As suggested by their name, stochastic Petri nets can account for variations caused 
by stochastic interactions of small numbers of molecules, and are also able to model large 
numbers of different types of molecule. They have been used to quantitatively model 
various intracellular signalling pathways. Other forms of Petri net have also been used to 
model biochemical pathways, including the steady-state behaviour of pathways [HKVO1]. 
3.2.4 Process Algebra 
Process algebra is the use of algebraic constructions to describe parallel systems in com- 
puter science [Bae03]. Many different types exist; ir-calculus is discussed here as a repre- 
sentative example. 
ir-Calculus 
ir-calculus is a formal language for specifying concurrent computational systems, and has a 
solid and widely investigated theoretical basis [Mi199]. Biochemical systems such as tran- 
scription circuits, metabolic pathways and signal transduction networks can be modelled by 
, 7r-calculus by treating molecules and their individual domains as computational processes, 
with potential interactions corresponding to communication channels [RSS01]. Stochastic 
ir-calculus is an extension of standard ir-calculus process algebra, and it accounts for prob- 
abilistic distributions that govern pathways, allowing quantitative descriptions [CDPT03]. 
ir-calculus is able to provide a similar description to Petri nets, but with a linguistic 
rather than graphical basis. While both can incorporate spatial information in modelling, 
the description is topological and thus somewhat unsuitable for the desired simulation of 
the NF-nB pathway. The ability to `model check' (a rigorous computational analysis of the 
model [CGP99]) process algebra models is often used to argue for their use in describing 
signalling pathways. However, due to the computational intensity of model checking, it 
is not possible to model check anywhere near the level of complexity present in signalling 
pathways, thus severely reducing the benefits of the technique. 
3.2.5 Cellular Automata 
Cellular automata are dynamical systems in which space and time arc discrete [Gut91, 
TM87}. Space is represented by a uniform grid, with each lattice point (or `cell', though 
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this can be confused with a biological cell) containing a few bits of information. The 
lattice points are updated synchronously, with their behaviour completely specified by 
local interaction rules. They are thus able to describe many types of concurrent dynamical 
system. 
Cellular automata rules have previously been developed to model biochemical molecular 
interactions. Each lattice point (representing a unit of volume) may be empty, or occupied 
by up to a specified maximum number of molecules being modelled, with the maximum 
number being dependent on the type of molecule [Wei02b, Wei02a]. 
Despite their theoretical scope, cellular automata are often limited by their computa- 
tional requirements. To model systems of significant complexity requires large numbers of 
lattice points and large numbers of iterations, and can result in impossibly long compu- 
tation time (a state space explosion). Moreover, although space is explicitly modelled, its 
uniformity prevents the incorporation of structure, and the simplicity of interaction rules 
places restrictions on what can be modelled. These concerns would severly restrict the 
ability of cellular automata to properly model signalling pathways. 
3.2.6 Different Approaches 
As mentioned earlier, representation and reasoning about the topology of signalling net- 
works has also been investigated [BCT+04a]. Rather than focussing on the simulation 
aspect of modelling (as with the techniques generally considered so far), such models treat 
signalling networks as a knowledge base from which queries can be answered. The ability 
of some of these methods to handle incomplete or partial information, as well as the capa- 
bility to update models with new information ('elaboration tolerance'), makes them well 
suited to modelling biochemical networks, albeit with restricted scope. 
Pathway logic is an algebraic formalism used to model and analyse signalling pathways 
at an abstract level higher than simulation. Biological structures are represented by alge- 
braic expressions, and biological processes correspond to rules that transform expressions 
from one to another. Pathway logic can predict and explain certain pathway behaviours. 
Other modelling techniques exist that provide a similar qualitative description, such as 
Boolean networks and recently BioSigNet-RR ('biological signal networks representation 
and reasoning'), which was developed to allow reasoning about networks with incomplete 
information [GCC+03]. Knowledge Representation in the area of Artificial Intelligence has 
also been used to describe biochemical pathways, including the NF-KB pathway, again 
allowing reasoning with incomplete information. Cellulat is an agent-based approach to 
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investigate pathway interactions [BCT+04b]. 
All the above quantitative and qualitative computational models treat biochemical 
networks as communication systems, focussing to a greater or lesser degree on the move- 
ment of information as opposed to the physics of interactions. While this is appropriate 
in many circumstances-indeed, even deliberately `unrealistic' models can provide useful 
insights [Bed99]-a more lifelike description of the cell (rather than an abstract pathway) is 
necessary in the case of the NF-nB pathway, where cell structure and mechanical stimula- 
tion are particularly important. Although several models overcome some of the problems 
associated with reaction kinetics models, none consider intracellular pathways as anything 
more than just the chemicals involved. For many aspects of the NF-rKB pathway, this must 
be rectified. 
3.3 Previous Models 
3.3.1 Hoffmann et al. 
The first widely accepted model of the intracellular NF-KB signalling pathway was that by 
Hoffmann et al. in 2002 [HLSB02]. In the model, reaction kinetics equations describe the 
concentrations with time of cytoplasmic and nuclear NF-, B, cytoplasmic and nuclear IKBc , 
-ß, -e, cytoplasmic IKK, and complexes thereof. Association, dissociation, degradation and 
catalysis of molecules are considered, and transcription and translation are accounted for, 
as shown in Figure 3.1. 
The rate constants used in the model are obtained from published results, previous 
experimental work, and model fitting to new experimental data. When implementing the 
model, initial NF-rB concentration is 0.1µM, with all other concentrations being zero. 
The model is allowed to run for 2000 minutes while IkB is produced and binds to NF- 
KB, causing its cytoplasmic localisation. Following this, IKK concentration is raised as a 
step function to 0.1µM, corresponding to pathway activation (where IKK refers to `active' 
IKK). Activation of the pathway is described as being by TNF binding to tyrosine kinase 
receptors, though so much of the pathway is abstracted away that the model could be of 
any stimulation resulting in IKK activation. Removal of the activation signal is modelled 
by a large increase in the IKK degradation coefficient. 
Transcription of InBß and IiBE is modelled as a continual zeroth order process (i. e. 
independent of any chemical concentration), which is completely unaffected by the pathway. 
Transcription of InBa is modelled in the same way, but with additional transcription caused 
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Figure 3.1: Schematic diagram of the processes modelled by Hoffmann et al. 
Arrows denote possible molecular processes, with molecular complexes shown by the grouping 
together of the constituents. The diagram shows all possible states of the molecules. Nuclear 
transport is modelled by changing a chemical into a `different' chemical rather than actual move- 
ment; the nuclear and cytoplasmic compartments in the diagram represent this change. IrcB- 
bound NF-nB is assumed not to enter the nucleus at all. InBa, -ß, -c all behave in the same way, 
and are shown as one molecule type in the diagram, though they each posses different rate con- 
stants for the reactions. IiB transcription is modelled by a constant production of mRNA that 
is independent of any events in the cell; InBa transcription in the model is additionally induced 
by the temporary binding of two nuclear NF-, c13 molecules (not shown in the diagram as the 
event does not affect the NF-nB). This is reportedly because NF-rcB binds DNA in a non-linear 
cooperative manner, although DNA itself is not modelled. InB translation is modelled as a first 
order conversion of mItNA into cytoplasmic InB. 
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by a second order process proportional to the square of nuclear NF-KB concentration. This 
corresponds to the binding of two nuclear NF-nB molecules, and is supposed to capture 
the fact that NF-rcB is a dimer, and so can apparently be presumed to bind DNA in a non- 
linear, cooperative fashion. The non-linearity is reportedly not essential for the qualitative 
behaviour of the model, though it is not clear why it is included since the reason provided 
is physically unreasonable. There is no evidence to suggest that two NF-, d3 molecules are 
required to cooperatively initiate transcription (there is only one binding site), and the fact 
that NF-4B is a dimer is irrelevant since in the model it is treated as a single molecule. 
The model was used to investigate the roles of different I KB isoforms in signal responses. 
Results for the model with each of the three isoforms included on its own were compared 
with biological results for mice cells with the relevant IcB-encoding genes deleted. Experi- 
ments used the average of multiple cells rather than single-cell analysis. Agreement between 
the model and experiment was good, and I, cBa was shown to be responsible for strong neg- 
ative feedback of the pathway, providing a fast turn-off of the NF-xB response. IrcBß and 
IKBe were shown to reduce oscillations in the system and stabilise responses during longer 
stimulations. The different isoforms thus apparently enable the system to provide both 
rapid short-term reactions to stimulation as well as stable long-term responses. 
Despite the successes of the model, it also has many flaws. The transcription terms in 
particular are debatable, with only IKBa transcription being affected in any way by NF- 
KB, and, as mentioned, even the way in which this occurs is questionable. So much detail 
of the transcription process is abstracted away that it is difficult to determine whether it 
is a good approximation to reality or whether the terms and constants used simply help 
replicate results rather than describe and explain the pathway. 
It is reported that the concentrations of nuclear IKBß-NF-tcB complexes and nuclear 
NF-KB are summed when plotting graphs of nuclear NF-KB since both have a similar 
transcriptional capacity, though this is not a true reflection of the actual model, where 
only nuclear NF-nB has any effect on transcription. 
The different volumes of the nucleus and cytoplasm are not considered with respect 
to their effect on the concentration of chemicals moving between the two compartments. 
This is a major issue, affecting to some degree the results of almost every chemical process 
modelled, including translation since the mRNA is formed in the nucleus but is translated 
in the cytoplasm. 
Time delays in the processes of transcription and translation are not considered, though 
they are known to be of key significance to the pathway, being of the order of several 
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minutes. It is possible to include time delays in differential equations, though solutions 
can be difficult. Furthermore, the discrete nature of transcription (with just one gene 
for each IiB isoform) is also neglected. Although the rate constants employed for these 
processes might be argued to account to some degree for both these issues, it is a rather 
unsatisfactory and inaccurate description of the situation. 
The biological results used to test the model were from multiple-cell averaging, thus 
being subject to the concerns discussed in Section 2.6. 
Much of the success of the model lies in its detailed and comprehensive rate constants 
and data fitting. However, possibly because the model is so finely tuned, small changes 
in some of these values can completely upset its behaviour. Since not all the values used 
can actually be completely accurate, and because biology itself is not so fragile, it suggests 
that the model is not necessarily a good description of the pathway but rather a successful 
replication of particular results. This severely limits it as a predictive tool. 
The model was originally implemented using Gepasi (version 3.1), which is a software 
package intended for simulating the kinetics of systems of chemical and biochemical reac- 
tions. Differential equations are created and numerically solved by the package, with the 
user supplying information about the possible reactions in the pathway, the rate constants 
of each reaction, and initial concentration of all chemical species. The E-Cell software 
package is able to perform a similar role, but with specific emphasis on intracellular re- 
actions rather than general chemical systems. Other differential equation solvers such as 
those in Cellerator or Matlab could also be used. 
3.3.2 Lipniacki et al. 
The model by Hoffmann et al. was developed by Lipniacki et al. in 2004 [LPB+04]. A key 
amendment was that the different volumes of the nucleus and cytoplasm were given due 
consideration with respect to nuclear transport. In addition, the model was fitted with 
better data for the number of free I, B, and transcription and translation coefficients were 
re-estimated by using data on a molecular level. Some processes such as free nuclear NF- 
KB export and dissociation of IKB and NF-nB were disregarded as having no significant 
impact on the model. 
Rather than investigating the effects of different IKB isoforms, only IkBa was modelled 
in order to examine other pathway features. IKBa was chosen as it is the most active 
and abundant isoform, and its deletion, unlike that of the others, is lethal. The effect 
of changing the relative volumes of the nucleus and cytoplasm was investigated, which 
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suggested that the ratio has a considerable effect on the overall dynamics and oscillation of 
the system. It is acknowledged that more detailed analysis of this is required however, as 
other parameters that were not modelled would undoubtedly also be affected by different 
ratios of nuclear and cytoplasmic volumes. 
The role of A20, the inhibitor molecule of IKK, was also explored. Like IrdB, A20 
transcription is induced by NF-, cB, and it also helps to deactivate the pathway. As opposed 
to inhibiting NF-, B directly, A20 stops the phosphorylation of I, cB by IKK, thus causing 
the accumulation of IkB in the cytoplasm, which inhibits NF-KB and deactivates the 
pathway. If A20 is removed from the model, IKB is continually degraded by IICK, and so 
cannot deactivate the pathway. 
The model is a successful progression of the model by Hoffmann et al., rectifying some 
of the original problems, and investigating new areas of the pathway, although time delays 
and stochastic effects are still not accounted for. Its consideration of the different nuclear 
and cytoplasmic volumes, as well as its use of more accurate data, shows some sections 
of the model by Hoffmann et al. to be unrealistic. However, the basic framework of the 
model is the same, and with some key alterations it is still successful in its description of 
the pathway, suggesting the fundamental approach does have scope. It models NF-rcB- 
induced transcription of IiBa as a first order rather than second order process, which is 
more realistic, and is still able to exhibit the required behaviour. The model was run using 
Matlab equation solvers. 
3.3.3 Developments with ODE Models 
In 2004, Nelson et al. reported a model exhibiting oscillatory behaviour in agreement with 
single cell data [NIE+04] rather than population data used by Hoffmann et al. They predict 
a critical role for the period of oscillation in determining the response of the cell and to 
permit the cell to distinguish between different pathways. While this is very plausible, no 
suggestion is given as to how this temporal signalling is made sense of. Furthermore, a 
more realistic consideration of oscillations would include time delays, but this would alter 
the quantitative behaviour of the model [Mon03]. 
The work of Nelson et al. prompted a debate with Barken et al. (based on the work 
of Hoffmann et al. [HLSB02]), raising concerns about the experimental data used in their 
respective models [NHS+05, BWK+05]. 
In 2005, Werner et al. developed the work of Hoffmann et al. by modelling interactions 
leading to IKK activation in further detail, investigating the effects of different antagonists 
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on pathway activation [WBH051. 
In 2006, Lipniacki et al. developed their ODE model by introducing stochastic differ- 
ential equations to describe the transcription of genes: due to the relatively large numbers 
of proteins and mRNA molecules in the cell, gene regulation is considered the main source 
of stochasticity [LPB+06]. The model demonstrates a significant variation between cells 
in different simulations; however, TNF stimulation causes synchronisation of cells, partic- 
ularly in the first 90 minutes following activation, progressively digressing thereafter. This 
suggests that population-level modelling of cells is valid within reason, while individual- 
level modelling of cells is also justified. 
3.3.4 Other Models 
Other pathway models include signal transduction models based on process algebra [CVGO, 
CGH]. An aim of these is to use model checking [CGP99] to investigate in detail the be- 
haviour of the model; this is extremely computationally intensive, so the models themselves 
must be relatively straightforward to be of use. Agent-based models of other biochemical 
systems have also been proposed, as discussed in Section 3.5.4. 
3.3.5 Review of Previous Models 
Although reaction kinetics models have been shown to be a useful method to investigate the 
NF-tB pathway, they are restricted in what they can model. They are unable to provide 
further insight into key transcription and translation processes due to their macroscopic 
view of all processes, and cannot deal with spatial considerations that can be of great 
significance to the activation of the pathway. Although time delays can theoretically be 
incorporated into the equations, little work has been done on this, and their solutions are 
especially difficult for large systems of equations. 
The existing reaction kinetics models should be referred to when developing a new 
model. A new model should build on their successful treatment of many of the pathway 
interactions, and utilise much of their comprehensive rate constants, but should also con- 
sider their assumptions and limitations. How previous models have dealt with unclear 
sections of the pathway should also help inform a new model, as should their results. 
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Figure 3.2: Representation of an agent interacting with its environment. External 
inputs are received by the agent and responded to by the rules of the agent according to its 
internal state. The resulting `outputs' could be a change in its state, communication with its 
environment, or to continue its current behaviour. 
3.4 Agent-Based Modelling 
Agent-based modelling originated in the 1940s with McCulloch and Pitts with finite state 
machines and von Neumann with cellular automata (as described in Section 3.2.5), though 
has since developed in generality and scope [Gut9l, TM87, E1e03]. Agents can model 
any system of discrete units. Applications range from modelling the effects of workers of 
different personality types in businesses, to assisting with air-traffic management systems 
in airports [VdVP96]. 
An agent is an autonomous entity whose behaviour is governed by the response of 
its own internal rules to interactions with its immediate environment. In agent-based 
(also known as individual-based) modelling, a system is described by a number of such 
agents, each of which behaves entirely according to its own internal set of rules triggered 
by the individual conditions that it experiences at any moment in time, as in Figure 3.2. 
Responses may be based on a number of key factors, namely the current internal state of 
the agent, its history or `memory state', and the influences that it is experiencing from 
either adjacent agents or the environment. Such influences are treated as communications 
of specific information. 
Agents can be represented by various different computational models. Representations 
are based on state machines, which are systems where the current input in combination 
with all past inputs determines the output. The effect of all previous inputs is represented 
by a state. 
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Figure 3.3: Representation of a finite state machine. Arrows represent processes and 
functions, as labelled. 
3.4.1 Finite State Machines 
A finite state machine is an abstract mathematical model of computation that represents 
computation as transitions through a finite set of states, as shown in Figure 3.3 [Elc03]. 
A stochastic finite state machine is defined as a tuple (N, 0, S, F, A, I), where: 
9N is a finite set representing all possible inputs 
"0 is a finite set representing all possible outputs 
"S is the finite set of states 
.F is the transition function operating on an input and state in N and S that causes 
changes in state 
"A is the mapping function operating on an input and state in N and S that generates 
output 
"I is the set of initial states (a subset of S) 
(a tuple is simply an array of data that is not necessarily all of the same type). 
The finite state machine is a valuable means to describe the dynamical behaviour of 
systems, providing an intuitive and easily comprehensible description. However, there 
are no communication channels between machines, meaning it cannot be used for agent 
modelling, and just one machine can be used to describe the entire system. A new state is 
therefore required to describe every possible state of the system, which can result in huge 
complication for even relatively simple systems. For example, to model the NF-KB pathway 
including spatial dimensions would require a different state for each possible combination 
of positions of molecules even before interactions are considered. There is also a lack of 
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modularity in the model, meaning the system is quite inflexible and requires an overall 
change to account for new or different requirements. 
It is possible for communication channels between machines to be defined to allow 
agent-based modelling, though the number of states required for each agent can still be 
unreasonably large. This is a similar situation to cellular automata. 
These problems make finite state machines inappropriate for modelling large systems; 
hence variations on finite state machines have been proposed for such purposes. Petri nets, 
as previously described (see Section 3.2.3), are a restricted version of finite state machines, 
providing greater analytical power. Extended versions of finite state machines have also 
been proposed to improve modelling capabilities, most notably of which is the X-machine. 
3.4.2 X-machines 
The X-machine is a formalism introduced by Eilenberg in the 1970s as a mathematical 
model of computation, and further developed by Holcombe and others from the 1980s 
onwards [E1e03]. It provides an intuitive method of modelling the functional behaviour of 
systems. 
The X-machine is similar to a finite state machine except that transitions are not simply 
labelled by inputs, but include functions that operate on inputs and a memory state, which 
allow the machine to be more expressive and flexible than a finite state machine. Stream 
X-machines (often referred to as simply X-machines) are defined as X-machines but with 
input and output restricted as being processed in a straightforward manner (effectively a 
string of symbols), as shown in Figure 3.4. 
A stream X-machine is defined as a tuple (N, 0, S, M, P, F, s, m), where: 
"N is the set of input symbols 
.0 is the set of output symbols 
9S is the set of states 
9M is the set of memory states 
"P is the type of the machine: a set of functions p that map an input and memory in 
N and M to an output and new memory in 0 and M 
"F is the function that gives the next state in S from the current state and function 
pin Sand P 
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Figure 3.4: Representation of a stream X-machine. Arrows represent processes and 
functions, as labelled. p is a function in P, as defined in the above text. 
.s is the initial state, a subset of S 
9m is the initial memory state, a subset of M 
Such an X-machine can be used to model various situations [Bar93]. For example, 
the input stream could be information supplied from a computer keyboard, and the out- 
put stream information to be passed to a monitor, though the model can be applied to 
many situations aside from those relating to computational processes. However, like finite 
state machines, basic stream X-machines cannot be used to formulate agent models; to 
achieve this, communication channels must be defined between machines. This creates 
the communicating stream X-machine, which is extremely well suited to modelling com- 
plex concurrent systems due to the flexibility and modularity of the machines [BHC+99]. 
Communication occurs by a `communication matrix', which contains a space for reading 
and writing information between every X-machine, allowing each machine to generate and 
receive influences from other machines. 
Communicating X-machines can therefore be used to define a system of agents where 
each agent interacts with other agents and changes state depending on both its environment 
and internal state. This is a natural and powerful method to model many systems. Each 
agent behaves in a structured way as follows: At any moment in time, the agent exists 
in a given internal state and a given internal memory state. Upon receiving an external 
influence, such as a communication from its neighbours or its environment, the agent will 
act according to one of a number of possibilities depending on its state. Following this 
it will change internal and/or memory state, generate a communication, or continue its 
current behaviour. 
An important property of such a model is that it is relatively straightforward to develop 
by adding new agents to the system, provided the state behaviour of the new agents and 
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Figure 3.5: Example of expanding a system. System (ii) is created simply by adding 
agent E to system (i) and defining the new communication channels. 
their communication channels with other agents in the system are precisely defined, as in 
Figure 3.5. The modelling process is thus extensible-an essential feature when modelling 
a complex system such as the NF-nB pathway. 
It is possible to generate computer simulations of such systems and experiment with 
the agent types and communication mechanisms; this provides a very powerful approach 
to help understand complex systems. 
3.5 Application of Agents to Pathway Modelling 
3.5.1 Previous Agent-Based Modelling 
Similar approaches have previously been used to successfully model a range of biological 
systems with a social element to their behaviour, including insect communities and ep- 
ithelial tissue [SHWO4, WSH+04, JHR04b, RJHRO5, JHR04a, WHW+04]. Many of the 
principles of previous agent-based models can be applied to an agent-based pathway model, 
such as communication methods and discrete time steps. Agent-based models depend on 
identifying coherent local entities that can be modelled individually, with a general method 
of communication that allows these agents to interact and adapt to circumstances. The 
choice of agent should be biologically natural and computationally meaningful; in the case 
of the NF-nB signalling pathway it is not so straightforward, hence a variety of types of 
agent will be required to decompose the system into meaningful sections. It is essential to 
ensure that the agents are both biologically plausible as entities and that their behaviour 
46 
is based on experimental measurements. 
3.5.2 Modelling the Pathway 
An agent-based model of the NF-rcB signalling pathway must clearly be based around an 
agent-based method of describing chemical interactions. Since this is crucial to the model, 
an appropriate chemical modelling method must be investigated. 
3.5.3 Agent-Based Chemical Interactions 
A successful model of the intracellular NF-AKB signalling pathway depends on an accurate 
model of chemical interactions. While an agent-based approach offers greater modelling 
scope than many other methods, it also requires greater definition of details due to its 
lack of implicit assumptions, such as molecular movement and how interactions occur. 
With the aim of using agent-based chemical interactions to model the NF-KB pathway, 
the chemical model must not only accurately describe chemical interactions, but should be 
sufficiently computationally efficient to permit simulation of such a complex system as the 
NF-icB pathway in reasonable time. The chemical model must strike a balance between the 
level of spatial resolution achievable with agents (precision) and the need for acceptable 
simulation times when applied to a large system (achievability). 
The most rigorous treatment of the movement of molecular agents is through the use 
differential equations that describe Brownian dynamics [Ris96]. With typical reactant con- 
centrations in biochemical networks, conventional Brownian dynamics simulations require 
time steps smaller than 10-10-10-9s; the use of Green's functions can increase time steps 
to 10-6-10-4s, which in combination with the increase in CPU time required per time step 
results in 2-5 times greater computational efficiency [vZRtWO5]. While this provides a sig- 
nificantly more viable method to model individual particles than conventional Brownian 
dynamics, it is still prohibitively slow if thousands of molecules are to be modelled over 
several minutes and even hours. 
Andrews and Bray [AB04] formulated an agent-based chemical interaction model in 
2004, implemented in a computer program called `Smoldyn'. The method is spatially ac- 
curate to almost the size of individual molecules. Each molecular agent is a point-like 
particle diffusing freely in three dimensions. The collision of reactive molecules results 
in the simulated reactants being replaced by a product or products. Using the rate con- 
stant, diffusion coefficient and simulation time step, the `binding radius' (the proximity 
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required to permit molecules to react) and `unbinding radius' (the separation required for 
molecules to move apart upon separation to prevent immediate re-binding) can be calcu- 
lated. Molecules move in a close approximation to Brownian motion at each time step. A 
detailed derivation of how to calculate the binding and unbinding radii for different types 
of reaction is presented, which permits time steps much larger than in Brownian dynamics. 
A method that holds for very large time steps is also mentioned, but dismissed as being 
unable to provide sufficient spatial detail. The same large time step method is used in 
the ChemCell model [PS05]. MCell is a similar program to Smoldyn but currently only 
permits reactions to occur at surfaces [SB01], which is rather restrictive. 
3.5.4 Previous Agent-Based Chemical Models 
The Smoldyn program has been used by Lipkow et al. to model signal transduction in the 
bacterium Escherichia coli [LAB05]. The large time step method is used to calculate inter- 
action radii. A rectangular container is used to represent the cell. The model demonstrates 
the feasibility of modelling thousands of individual molecular agents; it also highlights the 
importance of physical effects by changing the dimensions of the container. 
3.6 Modelling Summary 
Many modelling approaches and examples have been considered. Agent-based modelling 
has been demonstrated to be an appropriate and feasible approach to model the dynamics 
and physical effects of the NF-KB signalling pathway. 
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Chapter 4 
Agent-Based Chemical Interaction 
Modelling 
4.1 Formulating the Agent-Based Chemical Model 
As discussed in Section 3.5.3, the agent-based chemical model must not only be accurate 
but also sufficiently efficient, with a large enough time step, to be of use in modelling the 
NF-nB pathway; a balance must be struck between the benefits of agent-based modelling 
and the ability to run the model in reasonable time (no more than of the order of days). 
Since the primary concern is the investigation of the entire pathway over several minutes 
and hours, for which data exist, rather than individual molecular detail over short time 
scales, the large time step method of interaction as mentioned by Andrews and Bray [AB04] 
and Plimpton and Slepoy [PS05] is the most appropriate. A detailed description of this 
follows. 
4.1.1 Agent Interactions 
Reaction kinetics treats reacting chemicals as being uniformly well mixed and implicitly 
assumes that the number of molecules involved is large [PSQH06J. In contrast, an agent- 
based approach can treat each chemical molecule as a single identifiable entity, as shown 
in Figure 4.1. Thus any distribution and number of molecules (within computational 
limitations) is permissible. 
The agent-based model must of course agree with the corresponding reaction kinetics 
model in the circumstance where reaction kinetics can reasonably be applied (i. e. with 
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Figure 4.1: Chemical reactions. Reaction kinetics treats reacting chemicals &9 well mixed 
and uniform, as in (a), whereas an agent-based approach models each individual molecule, ýa. s in 
(h) 
large numbers of molecules of well-mixed chemicals). Since information about reacting 
chemicals is invariably given for such a situation, and because little information exists 
about individual molecular interactions, it is important that the necessary data for the 
agent-based model can be inferred from reaction kinetics. 
Rates of Interaction 
Take two reacting chemicals A and B combining to form C, with rate constant k (neglecting 
the reverse reaction for now): 
A+B4C 
If the concentrations of A, B and C at time t are a(t), b(t) and c(t) respectively, then 
from reaction kinetics: 
da(t) t) 
_ -ka(t)b(t) (4.2) 
Now if the magnitude of the change in concentration of A during a time step of At is 
Aa, as shown in Figure 4.2, then: 
a(t + At) = a(t) - Aa (4.3) 
The iterative process of Equation 4.3 acts as the basis for the agent-based interactions, 
with At a constant time step. 
Assuming At is sufficiently small, then: 
50 
(a) 
concentrati 
Ai 
A 
Figure 4.2: Generalised graph of concentration against time t for two chemicals 
A and B interacting to form C. With a time step of At, the change in A concentration is 
Aa, and the change in B concentration Ab. Since one A molecule interacts with one B molecule 
to form one C molecule, it follows that Aa = Ab 
Da -At 
da(t) t) (4.4) 
Substituting Equation 4.2 into Equation 4.4 gives: 
Aa = ka(t)b(t)Ot (4.5) 
Since one A molecule interacts with one B molecule to form one C molecule, it follows 
that lea = Ob, where Ab is the magnitude of change in concentration of B in time step 
At. Therefore the proportion of B molecules that interact with A at each time step is: 
Ab 
_ 
Da 
_ 
ka(t)b(t)t t= ka(t)Ot (4.6) 
b(t) b(t) b(t) 
If V is the volume of the container, and A and B are randomly distributed, then in 
order for the proportion of B molecules that interact with A to equal that obtained in 
Equation 4.6, it must hold that the total volume inside which A interacts with B (denoted 
V, ", as shown in Figure 4.3) is: 
V1= ka(t)OtV (4.7) 
The number of A molecules nQ at any time is given by: 
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Figure 4.3: Interaction volumes. In (a), the shaded volume shows the size of the total 
`interaction volume' Vi; (b) shows this volume `redistributed' over all the A molecules, giving 
each its own interaction volume v. B molecules are not shown for simplicity. 
na(t) = 103a(t)LV (4.8) 
where L is Avogadro's constant, and the factor of 103 is required if the concentration a(t) 
is measured in molars, with the rate constant defined accordingly (as is generally the case), 
and V measured in cubic metres. 
So each A molecule can interact with aB molecule if the B molecule is within an 
`interaction volume' v surrounding A of size: 
v_ 
11. 
_ 
ka(t)OtV 
_ 
kzt (4.9) 
na(t) 103a(t)LV 103L 
Assuming each individual interaction volume is spherical, then the maximum possible 
separation, or `interaction radius' r, of two interacting A and B molecules is: 
_3 
3kZt 
r 47r103L (a. 1 o) 
The rate constant can now therefore be used to deduce information on local interactions. 
The distance r will be larger than the combined molecular radii of A and B due to the 
length of the time step, since molecules move around in this time. The time step used 
must, of course he sufficiently small for this approach to hold (as assumed in Equation 4.4), 
though it must also be large enough for the average movement of each agent to exceed the 
binding radius so there is sufficient mixing of agents. Lengthening the time step will still 
yield accurate results over large time periods, but, clearly limits both spatial and temporal 
resolution. 
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Checking the result of Equation 4.10: if L is length and T is time, then the dimensions 
(denoted by square brackets) of r are: 
[r] =3 [k][At] = ý1(L3T-1)T =L (4.11) 
as required. 
It is worth noting that the same result is obtained regardless of whether A or B is 
used to calculate the interaction radius, as should be expected. However, unless A and B 
are both of the same concentration, it seems reasonable to question this statement: if the 
interaction radius is the same no matter how it was calculated, then the total interaction 
volume V, " will be different depending on whether A or B are `assigned' this radius, when it 
might be expected that it should be the same. On the other hand, if the total interaction 
volume were to remain the same, then this would require the interaction radius to change, 
which certainly should not be the case. 
It is actually correct that the total interaction volume changes (recall that Equation 
4.7 does indeed depend on the choice of molecule). Say there are more A molecules than 
B: if A molecules are each assigned the interaction radius, then V will be larger than if B 
molecules were assigned the radius, but the number of molecules with which they seek to 
interact is smaller. Likewise, if B molecules are assigned the interaction radius, then V is 
smaller, but the number of molecules they are seeking is larger. The number of A and B 
molecules in each other's interaction volume is consequently the same regardless. This is 
apparent in the derivation of r, though it may not be immediately obvious. 
This local interaction method can be used not only for large numbers of randomly 
distributed molecules, but also for any molecular distributions since the interaction radius 
obtained should hold whatever the circumstance. Such local interactions are key to the 
model, and allow its expansion to deal with any interactions-not just straightforward 
large-scale chemical reactions. 
Binding Decisions 
Only the possibility of interaction has been considered so far, and not the actual process 
of interaction. For instance, if more than one B molecule lies inside an A molecule's 
interaction volume, it must have some method to `choose' the most suitable B molecule 
with which to bind. This could be done at random, and with infrequent decisions to be 
made this would be of little consequence, but it is worth considering possible `decision' 
processes. 
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Figure 4.4: Possible movement of B molecules during a time step At in the centre- 
of-mass frame of an A molecule. Since the movement and orientation of molecules is not 
known during the time step, a random element is required in the interaction decision. 
A spherical interaction volume, uniform in all directions, is of course an abstraction of 
the process of interaction, since the orientation of molecules is vital for interaction. Clearly 
knowledge of orientation of molecules is beyond the scope of the model, especially since 
interactions occur during a time step where the orientations will have changed and the 
movement of the molecules is not exactly known, as represented in Figure 4.4. So although 
a spherical interaction volume is used, its shape is fairly arbitrary, and a randomness in 
the decision of interaction could be included to account for these issues--perhaps with 
an increasing probability of interaction for closer molecules, rather than just randomly 
choosing any molecule within the interaction radius. It is possible that even if a molecule 
is within the required distance to interact, interaction may not occur. This could be 
modelled by including a `threshold' over which the decision metric must be for molecules 
to interact, similar to the probability of interaction considered by Plimpton and Slepoy 
[PS05], remembering that this would affect the reaction rate since slightly fewer molecules 
would interact, thus requiring the interaction radius to be adjusted. In addition to this 
concern, it is clear in Figure 4.4 that it is possible for a molecule to have been able to 
interact during the time step, but due to the time at which calculations are performed 
it would not be considered. In fact, these concerns may be disregarded as having no 
observable effect on results, being beyond the resolution of the technique. 
So far, only association of molecules has been considered, though dissociation is of 
course also possible. Dissociation can easily be accounted for by making bound products 
separate randomly at a rate specified by the dissociation rate constant (using a uniform 
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random distribution initially, though this could be modified as appropriate). Although this 
is straightforward, it may be an unnecessary consideration since the rate of dissociation is 
often negligible, and its inclusion may simply unnecessarily overcomplicate computation. 
However, some features of the NF-KB pathway may depend on dissociation, such as the 
shuttling of NF-KB and IKB between the cytoplasm and nucleus in unstimulated cells 
[CDQ01], so the model must be able to deal with it if necessary. Unbinding molecules 
must separate sufficiently so as not to re-bind immediately [A1304]; this can be achieved 
either through an enforced separation, or an adequately large time step (or molecular 
speed) that they will separate far enough anyway (see Section 4.1.2). 
First-order reactions can be modelled by using a similar random change as would be 
used for two-particle dissociation. Higher-order reactions are modelled by the relevant 
number of two-particle local interactions (where the two `particles' become products of 
earlier interactions), as are enzyme interactions. 
Just as terms are added to reaction kinetics differential equations to deal with several 
chemical reactions, each molecular agent can seek interaction with several relevant types 
of molecule, with the appropriately sized interaction radius for each type. Instead of a 
list of linked differential equations to be solved, the agent model executes rules for each 
agent at each time step in accord with the state of the agent and its surroundings. In 
reality, molecular interactions are not tested for sequentially but are simply the result of 
continual attractions of all molecules involved. Without having a computer processor to 
simulate each agent (an impossibility for large systems), this clearly cannot be replicated 
in a model; instead, the order in which different agent interactions arc computed must be 
randomised at each time step in order not to produce any artificial systematic preferences. 
The method used to calculate interaction is not perfect, but it potentially allows path- 
ways to be modelled in greater detail than with differential equations. The discontinuity 
of attraction at the `interaction radius' is not quite a true reflection of reality, but it is 
sufficiently accurate for the purposes of many models, and it allows rate constant data to 
be used to infer information for local interactions. 
4.1.2 Agent Movements 
At every time step in the simulation, each molecular agent must move according to pre- 
defined rules. The above consideration of molecular interactions simply assumes good 
mixing of molecules, so some straightforward random motion of agents should be sufficient 
for the model to produce accurate results. Although detailed consideration of Brownian 
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motion [Cra75] would be the most rigorous treatment of this, the level of detail would 
be unnecessarily high, since the model does not seek to provide single-molecule detail. 
Furthermore, the movement of molecules in a cell is not always simple diffusion, but often 
active transport along scaffolds and membranes. Since the model will sometimes have 
to abstract such movement as random, it seems misleadingly and unnecessarily precise to 
have very detailed movement rules. More desirable is a simple but realistic rule for random 
movement that can easily be changed as necessary if different kinds of movement are to be 
modelled. 
The size of the molecules is assumed to be sufficiently small that collisions between them 
can be neglected for the purposes of their movement (molecules are treated as weightless 
particles). Molecules must collide with the sides of their container in order to stay within 
their confines, with a reasonable assumption being an elastic collision, which is simply a 
reversal of the component of their velocity which is perpendicular to the container at the 
point of collision. 
A simple rule for random movement of molecular agents is that each agent is initially 
randomly assigned a direction vector in 3 dimensions (assuming no net flow of molecules, 
just random movement), with a fixed average speed. At each time step, each agent moves 
a distance according to its speed, which is a random speed bounded around the average 
speed. The agent deviates from its direction by a random angle from the direction vector; 
this new direction replaces the previous direction from which to deviate at the next time 
step, as shown in Figure 4.5. The average speed of agents must be defined to reflect true 
molecular speeds, and the range of speed and direction deviation must be reasonable (see 
Section 4.4.4). 
These movement rules are reviewed in Section 6.4, and concerns with their results 
highlighted. 
Although not necessary for the chemical model, the movement of membrane-bound 
agents must also be accounted for to model the cell; this will be considered when formu- 
lating the pathway model (see Section 5.1.3). 
Due to the nature of agent movements, the overall energy of the system fluctuates 
slightly at each time step, but on average remains constant. A proper treatment of the 
energy of the system would be too complicated for the purposes of the model, especially 
since energy is provided for many processes by the metabolism. 
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Figure 4.5: Example of the movement of an agent at three successive time steps. 
Agent moves a random distance at each time step, with deviation from the average distance 
limited by the distance range (shown in inset box for the first time step), and deviation from 
previous direction limited by the angle range (which is 3-dimensional, i. e. conical). 
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4.2 Model Simulation 
Each agent is represented by an X-machine for the purposes of computation (sec Section 
3.4.2). The state of each agent's X-machine records to what (if anything) the agent is 
bound, while the memory of each agent's X-machine contains its physical location, meaning 
the number of states required to model the system is manageably small, since a different 
state of the agent is not required for each position it occupies. 
The physics of a molecule is modelled in the rules of the agent: namely, with what 
molecules it can interact, and how close it must be for this to be able to occur (as described 
in Section 4.1.1). If two molecules are able to interact (i. e. their rules state that it is 
possible), to do so they must both be in a state such that interaction at that time is 
allowed, as well as satisfying the criteria on proximity. If interaction occurs, then the 
state of each agent changes to a `bound' state; a new agent is not created, but each 
agent involved changes to a state such that the product behaves as a single entity, and 
can randomly separate. Agents could instead be destroyed and created for binding and 
dissociation, but this would unnecessarily remove information from the system. 
From a computational perspective, when agents interact, they directly communicate 
this to all other involved agents. This could instead be achieved by sending and receiving 
messages, which would give the same results and slightly complicate the simulation, but is 
important with regard to possible parallelisation of the model (CSHOG]. 
4.3 Chemical Reaction Results 
The chemical model described above is firstly tested against some arbitrary but general- 
isable reaction kinetics cases before being investigated in further detail (see Section 4.4). 
Specific cases of two-particle association, two-particle association and dissociation, and 
competing association are presented. Matlab is used throughout to run the model using 
a Pentium computer (see Appendix A for program code and Appendix C for a generic 
description of the algorithm used). 
4.3.1 Two-Particle Association 
With arbitrary concentrations of chemicals A and B combining to form C, the agent-based 
chemical model is initially as shown in Figure 4.6. 
Running the simulation with an arbitrary rate constant (neglecting dissociation) gives 
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Figure 4.6: Initial positions of A and B molecules interacting in a box. Concentra- 
tions of A and B are arbitrary but reasonable with respect to biochemical pathways (50nM and 
30nM respectively), as is the size of the box (a cube of side length 3.2µm). No C molecules exist 
at the start of the simulation. Positions of the molecules are random. 
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Figure 4.7: Agent model graph of number of molecules against time for chemicals 
A and B combining to form C. The rate constant is arbitrary but reasonable (10ßM-'s 1), 
and is similar to the rate constant of many reactions in the NF-ºd3 pathway. Initial concentrations 
are as in Figure 4.6 (with no C initially), but are expressed as the number of molecules to reflect 
the nature of the model. A time step of 0.5s is used here and in subsequent simulations. 
the results of Figure 4.7. A time step of 0.5s is used here and in subsequent simulations; 
further consideration of this is given in Section 4.4. The same rate constant and initial 
chemical concentrations are used in a numerical solution of the corresponding reaction 
kinetics differential equations to give the results of Figure 4.8. 
The agreement of the agent model and reaction kinetics model is clearly visible in 
Figure 4.7 and Figure 4.8. It is worth noting that the same results of Figure 4.7 are 
achieved regardless of whether A or II is assigned the interaction radius, as stated in 
Section 4.1.1. The random nature of the interactions can be seen in the fluctuations of 
the graph in Figure 4.7; these fluctuations decrease as the number of molecules involved 
increases, and become more pronounced as the number of molecules decreases, as would 
be expected (results not displayed). 
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Figure 4.9: Agent model graph of number of molecules against time for chemicals 
A and B combining to form C, including the reverse reaction. The forward reaction 
rate constant and initial concentrations are the same as previously. The reverse rate constant is 
arbitrary but reasonable (0.01s-1), although to make its effect more obvious it is about an order 
of magnitude larger than the dissociation rate constant of many of the reactions in the NF-rcB 
pathway. 
4.3.2 Two-Particle Association and Dissociation 
Although it may not always be necessary to include in the pathway model, it is worth 
testing that agents can also be used to accurately model dissociation. A similar process 
would also be used to model a simple first order chemical reaction. The results for a reaction 
including dissociation are shown in Figure 4.9, with the differential equation solution in 
Figure 4.10. 
The agreement between the agent model and reaction kinetics model in the circum- 
stance where standard reaction kinetics may reasonably be applied is again clear in Figure 
4.9 and Figure 4.10. The increase in fluctuations in Figure 4.9 over Figure 4.7 is due to 
the randomness of dissociation increasing the overall randomness of the process. 
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Figure 4.11: Agent model graph of number of molecules against time for chemi- 
cals A and B combining to form D combined with A and C combining to form 
E. The rate constant for A and B association is 106M-1s-1, and for A and C association is 
5x 105M-1s-1. The initial concentration of A is 5OnM, and initial concentrations of B and C 
are both 30nM. There are no D or E initially. 
4.3.3 Competing Association 
As molecules are often able to interact with more than one other type of molecule, this 
must also be tested in the agent-based chemical model. Neglecting dissociation, Figure 
4.11 shows the agent model result of the reaction A+B -3 D combined with A+C -ý 
E. The equation result for the same reaction is shown in Figure 4.12. 
Agreement of the agent model with reaction kinetics equations is again very good. The 
agent model appears to successfully recreate the basic reactions necessary to describe the 
NF-KB pathway, and indeed many other biochemical pathways. However, a more detailed 
investigation of the model-beyond simple comparisons with specific reactions-should be 
carried out to ensure its accuracy and understand its limitations. A consideration of this 
follows. 
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4.4 Performance of Model 
4.4.1 Features to be Investigated 
Although time course results from the agent-based chemical model show good agreement 
with ODE solutions for specific chemical systems, the model must be investigated in greater 
detail in order to understand better the accuracy and performance of the model, specifically 
as regards the effects of: 
" the number of agents on the accuracy and time taken to run the model. 
" the length of the time step on the accuracy and time taken to run the model. 
" the movement of agents on the accuracy and time taken to run the model. 
To evaluate these effects, the model is executed for a particular chemical system and 
each parameter is changed in turn. Accuracy is defined by how close the model comes to 
replicating results obtained by ODEs over the same time period; the accuracy of results in 
situations where the assumptions implicit in ODEs no longer hold (with low numbers of 
molecules) is also considered. Accuracy will be tested at two different time points, one near 
saturation and one away from saturation; this will indicate how well the model performs 
throughout a simulation. The effects of changing initial concentrations and rate constants 
are also investigated; these should have no effect but must be verified. 
4.4.2 Effect of the Number of Agents on Accuracy and Simula- 
tion Time 
The effect of different numbers of agents on the accuracy of results and simulation time 
is shown in Figure 4.13. The model is run for the reaction A+B -- C with initial 
concentrations of A and B as 50nM and 30nM respectively, and association rate constant 
106M-1s-1 (as in Section 4.3.1); the container size is scaled appropriately to maintain 
the correct molecular concentrations with different numbers of agents. Results from the 
simulation are compared with those obtained from ODEs after 50s and 150s, where the 
system is close to and far from saturation respectively; concentration of C molecules is 
used to measure accuracy. 
Figure 4.13 shows that at both 50s and 150s, with more than 1,000 agents model ac- 
curacy is very good and is invariant, which is as should be expected. Simulation times 
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Figure 4.13: Dependence of model accuracy on number of agents. Effect of changing 
number of agents on simulation time and accuracy (as compared with ODEs). Time step fixed 
at is. Average speed fixed at 1.4 x 10-7ms-1. Accuracy of results tested after 50s (away from 
saturation, dashed line) and after 150s (close to saturation, solid line). Error bars Show onC 
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increase with the numbers of agents, as expected. Accuracy close to saturation is consi- 
tently better than away from saturation due to the decrease in the number of degrees of 
freedom for the system near saturation. Accuracy as compared with ODEs deteriorates 
below around 1,000 agents; this requires further investigation as the assumptions implicit 
in ODEs no longer hold with low numbers of molecules, so a different measure of model 
accuracy is required. 
To test accuracy with low numbers of agents, the agent model is compared with results 
from the Gillespie algorithm for the same system, as shown in Figure 4.14 [Gil77, ScaOG]. 
Results are normalised around ODE results at the appropriate time for straightforward 
comparison. 
Figure 4.14 demonstrates good agreement between the agent model and the Gillespie 
algorithm; this is good evidence that stochastic effects are properly accounted for. While 
results are similar to those obtained from ODEs, stochasticity is an important conceptual 
feature, and the agent model displays similar behaviour to the Gillespie algorithm. 
4.4.3 Effect of the Time Step on Accuracy and Simulation Time 
Running the same simulation as above-but with a fixed number of agents and different 
time steps-affects accuracy and simulation time as shown in Figure 4.15. 
Figure 4.15 shows that with time steps greater than 1s, the model produces very accu- 
rate results, while model accuracy rapidly deteriorates with time steps below 0.5-1s. The 
time taken to execute the simulation is inversely related to the length of the time step (as 
should be expected), so the benefits of a long time step are two-fold, though clearly this is 
paid for in loss of temporal (and consequently spatial) resolution. 
In Figure 4.15, the greatest temporal resolution achievable with good model accuracy 
is approximately a is time step. However, the length of the time step cannot be taken 
in isolation for its effect on accuracy-the length of the time step affects accuracy due 
to the change in the mixing of agents at each iteration, so it is the combination of the 
length of the time step with the average speed of agents that is important (i. e. average 
distance moved). So in the above simulation, the best spatial resolution attainable while 
still achieving accurate results is 1.4 x 10-Tm (a time step of Is). Although this is orders 
of magnitude larger than molecular sizes, it offers an acceptable level of precision. 
In the simulation in question, the interaction radius of agents is 7.3 x 10"8m. From the 
above empirical results, it appears that agents must move approximately twice as far as 
this per iteration to achieve sufficient mixing, which is intuitively reasonable-it seems the 
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interaction volume of an agent should not on average overlap with its interaction volume at 
the previous time step, since this area has already been tested for interaction, and despite 
the fact that both chemical species move, the content of the volume in question is more 
likely than not to be the same. Hence temporal and spatial resolution are dictated by 
the rate constant and agent speed, with greatest possible temporal resolution limited to 
the time required for an agent to move twice the length of the interaction radius (which 
of course itself depends on the time step), and spatial resolution limited to twice the 
interaction radius, or: 
tmin 2r (4.12) =v 
Xmin = 2r (4.13) 
where r is the interaction radius, v the average agent speed, tm; n the minimum possible 
time step (or greatest temporal resolution), and xi,, the greatest spatial resolution. 
Substituting Equation 4.12 into Equation 4.10 and rearranging gives the limit for tem- 
poral resolution as: 
tmin = CV-3/2 (4.14) 
where C=, with L Avogadro's constant and k defined in ll1-ls'1. It is worth 
noting that if Equations 4.12 and 4.13 were instead dependent on a different multiple of r 
(y, say, instead of 2), then C= 
V 
-. 410 L 
Substituting Equation 4.14 into Equation 4.13, it therefore follows that: 
xmin = CV-1/2 (4.15) 
Checking the dimensions of Equation 4.14 and Equation 4.15, with length L and time 
T: 
[tmin] = [C][v-3/2] = (L3/2T-1/2)(L-3/2T3/2) =T (9.16) 
[Xmin] = [C][v-1/2] = (L3/27. -1/2)(L- 1/2 =L (4.17) 
as required. 
These expressions for temporal and spatial resolution will be tested below. Investigation 
of the effects of agent movements on model accuracy follows. 
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Figure 4.16: Movement of agents in a simulation. Visualisation of the movement of 
three agents in a simulation over 50s, with a time step of is and average speed of 5.9 x 10'Tms'I. 
Initial and final positions of each agent are shown. Marked lengths are in metres. 
4.4.4 Effect of Agent Movements on Accuracy and Simulation 
Time 
The most important feature of the model's movement rules to investigate is the average 
speed of agents. It is also necessary to explore the `randomness' of movement of agents, 
both the change in direction of agents and the change in distance moved at each time step. 
Before investigating these effects, it is worth seeing how agents move in the model; Figure 
4.16 shows the movement of agents from a simulation. 
Figure 4.16 shows `reasonable'-looking movements of agents, with some randomness of 
movement between collisions with the container walls. Further investigation of this will 
begin with the average speed of agents. Clearly the average speed of agents in the model 
should be a `fixed' parameter that is dependent on data about the system in question. 
However, the effects of different speeds of agents on model results must be investigated; 
this will evidently be closely linked with the effects of different time steps, as discussed 
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Figure 4.17: Dependence of model accuracy on speed of agents. Effect of changing 
agent speeds on simulation time and accuracy (as compared with ODEs). Total number of agents 
fixed at 3,568. Time step fixed at 1s. Accuracy of results tested after 50s (away from saturation, 
dashed line) and after 150s (close to saturation, solid line). Error bars show on(, standard error 
of the mean from 10 simulations. 
above. Altering the average speed of agents, with other parameters fixe& produces the 
results of Figure 4.17. 
As with changing time steps, model accuracy increases tip to a plateau with increasing 
average speeds of agents. Simulation time is unaffected by different, average speeds, as 
expected. 
Using either Equation 4.14 or Equation 4.15, with the rate constant and time step 
used in Figure 4.17, an average speed of at least 5.9 x 10-7ms-' is necessary for maximal 
accuracy of the model; this is evident in Figure 4.17 where a plateau is reached at. this 
average speed (more markedly in the results away from saturation, which are less influenced 
by other factors). This strongly supports the validity of Equation 4.14 and Equation 4.15. 
For the same reaction as used in Figure 4.17 but with agents with an average velocity lower 
than 5.9 x 10-7ms-1, a larger time step would be required to give accurate results. 
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Figure 4.18: Dependence of model accuracy on angle through which agents can 
move at each time step. Effect of changing agent movements (magnitude of change in 
direction) on simulation time and accuracy (as compared with ODEs). Total number of agents 
fixed at 3,568. Time step fixed at 1s. Average speed fixed at 5.9 x 10-7ms-1. Accuracy of results 
tested after 50s (away from saturation, dashed line) and after 150s (close to saturation, solid 
line). Error bars show one standard error of the mean from 10 simulations. 
Although a minor feature of movement rules, it is worth checking that changing the 
angle range within which agents can deviate from their present direction, and also the 
distance range (as shown in Figure 4.5), does not have a significant, effect, on results, as 
displayed in Figure 4.18 and Figure 4.19. 
Figure 4.18 and Figure 4.19 both show no effect on model accuracy when altering the 
parameters for the `randomness' of movement, showing they are of minor importance for 
the model, which is a desirable feature of the model. This is expected due to the limits 
of spatial resolution in the model (stated in Equation 4.15), meaning that alterations in 
movement which are smaller than this should not affect results. However, this does not 
mean that randomness of movement is unnecessary since some randomness is required to 
minimise systematic bias towards any particular behaviour and over-dependence on initial 
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Figure 4.19: Dependence of model accuracy on change in speed of agents at each 
time step. Effect of changing agent movements (magnitude of possible variation of distance 
moved) on simulation time and accuracy (as compared with ODEs). Total number of agents fixed 
at 3,568. Time step fixed at is. Average speed fixed at 5.9 x 10-7ms Accuracy of results 
tested after 50s (away from saturation, dashed line) and after 150s (close to saturation, solid 
line). Error bars show one standard error of the mean from 10 simulations. 
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conditions. 
Because of the nature of the movement rules, changing the time step will change overall 
agent movements slightly because it changes the frequency with which they can change 
direction. However, a changing time step has a greater effect on the model due to its 
effect on the mixing of agents (as discussed). Its effect on results due to altering agent 
movements could be assessed by testing it at time steps above where the time step affects 
the mixing of agents (i. e. above the minimal temporal resolution), but its effect can be 
disregarded as negligible in light of Figure 4.18 and Figure 4.19. 
4.4.5 Effect of Rate Constant on Accuracy and Simulation Time 
It is essential that the model produces accurate results for any rate constant; this is demon- 
strated in Figure 4.20. 
The slight positive trend in accuracy after 150s is due to the the system becoming 
increasingly close to saturation as the rate constant increases, so nearly all molecules are 
bound. The accuracy is effectively constant though. The decrease in time taken for the 
simulation is due to the decrease in computation required to seek interaction when more 
molecules are bound. 
4.4.6 Effect of Initial Concentration on Accuracy and Simulation 
Time 
As with different rate constants, the model must produce accurate results for any initial 
concentrations of molecules, as demonstrated in Figure 4.21. 
After 150s, accuracy is high with low initial concentrations of chemical A due to the 
system being close to saturation, and becoming further from saturation with increasing 
concentrations of chemical A. This very slight decrease in accuracy is 'over-ridden' by the 
larger number of agents involved as the concentration increases (as in Figure 4.13). Away 
from saturation there is simply a slight increase in accuracy with increasing numbers of 
agents. Accuracy is effectively constant though. The increases in simulation times are due 
to increasing numbers of agents. 
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association rate constant on simulation time and accuracy (as compared with ODES). Total 
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4.5 Summary of Chemical Model 
An agent-based model of chemical interactions has been formulated for use in systems where 
spatial detail is required, but also where reasonable simulation times are more important 
than single-molecule resolution. This means the model is very suitable for modelling in- 
tracellular pathways, fulfilling the objectives stated in Section 4.1. 
The model has been investigated in some detail to ensure it behaves as necessary for 
modelling chemical pathways; its spatial and temporal resolution have been defined, and 
its results compare well with both ODE and stochastic results in appropriate situations. 
It is worth noting that the agent model only ever systematically under-estimates rates 
of interaction (this under-estimation tends to zero with properly defined parameters). As 
discussed in Section 4.4.3, the model has a tendency for agents not to mix sufficiently; it is 
important that a sufficiently large time step is used in relation to the average agent speed 
(as defined in Equation 4.14) for the model to produce the most accurate results possible. 
While the model has been demonstrated to be successful in a range of situations, there 
is always scope for further investigation of its properties. However, rather than become 
deeply involved in details of what is supposed to be a reasonably straightforward agent- 
based method, emphasis is better placed on pathway modelling and investigation. Further 
work on agent interactions could then be guided by this; if, for instance, it were found 
that stochastic effects in the pathway must be investigated in further detail, then it would 
be appropriate to return to the chemical model for further analysis. However, if the 
pathway model is more focussed on other features of the system, then greater investigation 
of stochastic effects, for example, would be unnecessary in the chemical model. 
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Chapter 5 
Agent-Based Modelling of the NF-rB 
Signalling Pathway 
5.1 Formulation of Model 
Formulation of the pathway model requires the consideration of what the model seeks to 
achieve, how and why it will do this, and how its suitability will be measured. Successful 
agent-based modelling of the pathway depends on the following: 
1. Specifying the `population' level to be modelled-what areas of the pathway should 
be investigated; where the start and end are defined; and what external influences 
interact with the pathway, including other pathways. This should be directed by: 
(a) The questions about the system that need answering. 
(b) The biological data that exist to inform and verify the model. 
(c) The direction future work may take. 
2. Identifying the individual components of the system to be modelled as agents. This 
should be directed by the above, as well as: 
(a) The levels at which constituents of the system may be treated as a single entity. 
(b) The areas of the system that are most important for its operation. 
(c) The areas of the system that are most central to the questions the model seeks 
to address. 
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(d) The level of detail required, both to form a realistic model and for results to be 
useful. 
(e) The amount of computing power and time available. 
3. Verifying the model-both at the individual and system level-against existing data. 
4. Forming testable predictions from the model, which should be directed by the same 
considerations as used to specify what should be modelled at the population level, 
as well as: 
(a) The level of detail the model provides and the limits in which it operates. 
5. Validating predictions of the model with experimental results. 
Since the pathway is a set of molecular interactions, the individual molecule is a natural 
choice of agent for the model; a `lower-level' agent would be not only unnecessary and very 
difficult to include, but an actual hindrance to the model both in terms of computation 
and tractability; and a `higher-level' agent would be too much of an abstraction for much 
of the system, providing little benefit over other modelling approaches. 
To a certain extent, the pathway model can be formulated simply by defining the nec- 
essary chemical reactions in the agent-based chemical model (see Chapter 4), which has 
already been largely verified. However, further model details must also be defined, in- 
cluding cellular compartments and shape, more abstracted peripheral agents, and pathway 
activation. 
5.1.1 Main Features to Model 
Due to its importance to the NF-i B signalling pathway, the available biological data, and 
its relative simplicity, TIR pathway activation is the starting point for modelling. 
Each NF-tcB, Ir ,, B and IKB-kinase (IKK) molecule is an individual agent, as are the 
TIRs, as depicted in Figure 5.1. Importing and exporting nuclear receptors are also mod- 
elled as individual agents, which is an abstraction of the transport mechanism described 
in Section 2.3.3 (the nuclear pores are not directly modelled, but nuclear receptors are 
restricted to the nuclear membrane and assumed to each have free access to a pore). 
In addition to the model's key agents, there also exist temporary agents and other 
devices to deal with the complexities and computational limitations of the system. IL-1 
cytokines are not modelled as agents but are instead treated as a whole chemical entity 
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Figure 5.1: Simplified diagram of principal pathway agents. Interactions between two 
agents may only occur if both are within a defined proximity and their internal states permit. 
Defined internal states of the receptors and genes are shown; other agents have more possible 
states and are not marked on the diagram. Soluble agonists and receptor-binding molecules are 
not modelled as agents, as described in the text. 
whose fluctuating local concentrations on the cell surface arc required to rise above a certain 
level in order to initiate signal transduction in nearby dormant TIR agents. 
A similar method is used at the intracellular domain of the TIR's signal transduction, 
where local concentrations of certain molecules in the cytoplasm must be above a certain 
level in the vicinity of an active TIR to complete the process. Following this, a temporary 
agent with an internal time delay is created to account for the cascade that triggers the 
upstream kinases, including IRAKs. This allows for the complex molecular interactions 
and cross signalling with other trigger mechanisms prior to IKK activation. Clearly this 
can be developed as required by decomposing the cascade into as many agents as necessary. 
At the other end of the pathway, a similar temporary agent method is used to account for 
transcription and translation, resulting in the creation of new IKB agents. The inhibitor 
of primary interest to the model is I, cBa-the most critical and abundant inhibitor (see 
Section 2.2.4)-but other isoforms can also be included as necessary. 
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Figure 5.2: States and transitions of NF-nB. The possible state transitions shown 
depend on an agent's immediate environment. For example, bound to unbound transitions in the 
cytoplasm may be due to random thermal dissociation, or may involve IICK; in the cytoplasm 
the same transition can only occur by random thermal dissociation since IKK does not exist in 
the nucleus. 
5.1.2 States of Agents 
Each agent exists in one of a set number of possible states at any time. For example, an 
NF-nB molecule may be free in the cytoplasm, free in the nucleus, bound to IKB in the 
cytoplasm, bound to Ir. B in the nucleus, being transported in an importing or exporting 
nuclear receptor while being either bound or unbound to IrKB, or initiating gene transcrip- 
tion, as shown in Figure 5.2. At every time step, each agent observes its surrounding 
environment, seeking interaction in accord with its present state, and if successful, con- 
sequently changing state. For example, if NF-KB is unbound in the nucleus, it may bind 
to nuclear IKB, move through the nuclear membrane with an exporting nuclear receptor, 
initiate gene transcription, or remain unbound in the nucleus, depending on the proximity 
and availability of the appropriate agents, with a weighting for the likelihood of each, and 
an appropriate time delay where necessary. If the same agent were instead unbound in the 
cytoplasm, for example, it may bind to cytoplasmic rather than nuclear IKB, move through 
the nuclear membrane with an importing as opposed to exporting nuclear receptor, and 
would not be able to initiate gene transcription. 
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5.1.3 Movement of Agents 
Membrane-Bound Movements 
Non-membrane-bound agent movements are as described in Section 4.1.2. However, the 
movement of membrane-bound agents must also be considered. This follows the same 
principles as other agent movements, except the movement must be constrained to two 
dimensions. The movement rules therefore rely on the geometry of the surface; as a first 
approximation to the shape of cells, this is a spherical cell boundary with a concentric 
spherical nucleus. 
Each membrane-bound agent is assigned a random initial position on the membrane, 
an initial direction of movement, an average speed (converted to an angular speed) on 
the membrane, a possible range of deviation from this speed at each time step, and a 
range of angles through which its movement can deviate at each time step. Each agent is 
also assigned a direction of movement in terms of theta and phi values in spherical polar 
coordinates (with the origin at the centre of the cell, as opposed to the origin being at the 
position of the agent for non-membrane-bound movements). At every time step each agent 
deviates from its average speed by a random amount and from its previous direction by 
a random amount, both within defined limits, as though Figure 4.5 were curved over the 
membrane (see Appendix 13 for movement code). 
Boundary Collisions 
Clearly, membrane-bound agents do not undergo boundary collisions. However, the move- 
ment of all other agents requires boundaries to be considered. Since the boundaries are 
spherical, elastic collisions are simply a reflection of the radial component of the movement 
of the agent, as shown in Figure 5.3. It is worth considering the length of the movement 
at each time step in relation to the size of the container, since this could result in the 
spurious results also shown in Figure 5.3, though with reasonably sized time steps this is 
not a problem. 
5.1.4 Model Simulation 
When running the model, the latent system is allowed to reach a steady state prior to 
activation. The soluble agonist is then introduced to the cell surface for a fixed period. 
At each time step, the order in which each set of interactions is computed, such as NF-tcl3 
association with IKB, is randomised to ensure that no interaction is given priority in the 
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Figure 5.3: Example of an agent undergoing an elastic 'collision' with a mein- 
brane. The random movement vector a of a cytoplasmic agent has moved it outside the cell. 
Reversing the radial component r of its displacement outside the cell puts it back into the cyto- 
plasm, as though an elastic collision with the membrane has occurred, with resultant vector a?. 
Note that if the speed of the agent is too great, as with vector b, it could move so far out of its 
compartment that this method would not return it to the cytoplasm. 
model as a whole, as discussed in Section 4.1.1. The generic algorithm is displayed in 
Appendix C and the parameter values used are shown in Appendix D. 
An image of agent positions in the model is shown in Figure 5.4. The cell is scaled 
down to reduce computation; this is justified in light of the results of Figure 4.13, and is 
accepted practice in comparable stochastic differential equation modelling [BT03]. Scaling 
will affect noise in the system, which should be accounted for if stochastic effects are to be 
considered in detail. 
5.2 Basic Pathway Operation 
5.2.1 Biological Results for Basic Pathway Operation 
Biological results for a relatively simple area of pathway operation are necessary to verify 
the model. Data for IL-1 stimulation of the pathway are used, which were obtained from 
monitoring the pathway in live cells using GFP-tagged NF-rKB and I, cßa molecules by 
confocal microscopy, as described in Section 2.6 [YRQ03, CDQO1, CCDQOO]. Simultaneous 
observation of the NF-KB subunit relA and InBa were carried out using cyan (ECFP) and 
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Figure 5.4: Three-dimensional visualisation of the positions of agents in the 
model at a moment in time. Positions are random within each agent's confines. The cell 
is spherical, with a cell membrane, nuclear membrane, cytoplasm and nucleus. The genes that 
NF-KB can activate are placed randomly along a line at the centre of the nucleus, though are 
not shown. The cell is scaled down from an average diameter of around 10µm to a diameter of 
2µm to reduce computation, containing of the order of 1,000 agents. Concentrations and rate 
constants of molecules are based on biological data. 
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Figure 5.5: Images of cells co-transfected with NF-KB and IK-B". Images of single 
cells co-transfected with ECFPre1A and I, cBeeEYFP. Prior to stimulation, both components are 
located in the cytoplasm (top row). Following pathway activation, NF-KB translocates to the 
nucleus while IkBa and NF-rcB-IkBce complex levels fall (bottom row). Scale bar 10µm. Figure 
from Palmer [Pa106]. 
yellow (EYFP) variants of GFP respectively, and complex formation assessed by measuring 
fluorescence resonance energy transfer (FRET), with ECFPrelA the donor and IKBaEYFP 
the acceptor (see Figure 5.5). Experimental results for one such experiment are graphed 
in Figure 5.6. 
5.2.2 Comparison of Model with Biological Results 
Running the model for the same situation as shown in Figure 5.6 gives the results in Figure 
5.7. The model shows close similarity to single-cell results, suggesting the model works 
well. In particular, nuclear translocation of NF-KB following stimulation and the reduction 
of cytoplasmic molecular levels are in good agreement with experimental observations over 
the same time period. 
Constants used in the agent-based model give reasonable results over a range of pa- 
rameter values. Figure 5.8 shows model results for the same situation as in Figure 5.7, but 
with rate constants changing between half and double the values used previously. 
Figure 5.8 demonstrates that as would be hoped- rate constants have a clear effect 
on results (i. e. the model does not produce the same outcomes regardless of inputs), but 
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Figure 5.6: Single-cell experimental results for 1 hour following IL-1 stimulation. 
Quantitation of data as shown in Figure 5.5. Data from Yang [Yan03]. 
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Figure 5.7: IL-1 stimulation in model. Model results for the same stimulation as Figure 
5.6. Results shown are for a single cell. Standard error 5.4% from 12 simulations for final NF-KB 
nuclear concentration. 
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Figure 5.8: Varying rate constants in the simulation. All the rate constants for chemical 
reactions are varied in equal steps between half and double those used for Figure 5.7. Half the 
rate constants increase from a factor of 0.5 to 2 in panels a to c, while the rest decrease from 2 to 
0.5, to remove any particular bias in results, since the variation is supposed to he quite arbitrary. 
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equally the model is not over-dependent on data, with similar behaviour being produced 
within reasonable ranges of rate constants. 
5.3 Further Pathway Details 
With the model established as providing a good representation of pathway operation-at 
least in the circumstances already described-it is sensible to investigate how the model 
behaves in different situations, and whether this agrees with existing understanding and 
data. This will show the scope of the model, and provide a basis from which to form 
predictions. 
5.3.1 Changing Receptor Levels 
A simple and sensible investigation of the model is to discover the effect of changing 
levels of surface receptors on downstream signalling events, thus testing operation across 
the pathway. Figure 5.9 demonstrates expected positive correlation between increasing 
receptor levels and pathway activity at the level of NF-KB nuclear translocation. 
5.3.2 Changing IKK Levels 
Having above looked at an effect across the system, it is worthwhile to focus on a specific 
step in the pathway and investigate its effect at different levels. IKK is crucial to activation 
of the pathway, so it is of interest to investigate the effects of changing levels of the protein. 
Figure 5.10 and Figure 5.11 both demonstrate a limited range in which changing IKK 
levels impact on the rest of the system; in Figure 5.10 this is shown in terms of nuclear 
NF-icB translocation, and in Figure 5.11 in terms of IkBa phosphorylation and NF-icB- 
InBa complex levels. These results confirm the mechanisms of the pathway, whereby IKK 
phosphorylates InBa, thus releasing NF-nB and lowering NF-1B-IKBa complex levels, 
which results in NF-KB nuclear translocation. Above a specific IKK concentration the 
phosphorylation step in the pathway becomes saturated. 
5.3.3 Extended Time Course 
The model is less restricted than experiment in the duration and detail it can observe. 
Figure 5.12 shows behaviour of the system over 10 hours following activation; gene tran- 
91 
10 -_- _T 
- Double TIR levels 
j9 Normal TIR levels I 
8 
ö6 
5 
$4 
co 
k 
ti 3 
z 
Z 
fN 
il" 
0 
400 
1' erb 'v 
ljý 
f_ 
1400 2400 3400 4400 5400 6400 
tim. Is 
Figure 5.9: Effect of changing levels of cell surface receptors. The model is run with 
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93 
50 100 150 200 250 300 
IKK concentration /arbitrary units 
100 
m 95 
Co 
o 90 
s 0. 
U) 85 
_I_- 
CL 
m 80 
0 75 
%0 
C N 
65 
60 
55 
5c 
IKK concentration /arbitrary units 
n 13 c 
Figure 5.11: Effect of IKK concentration on In Bar phosphorylation and 
NF-KB-IKBa complex levels. Different IKK levels affect IK, Bn phosphorylation and NF- 
kB-IiBa complex levels in accord with Figure 5.10. 
wc 
c 
I- 
L 
Z I- 
U- 
EC 
Cl, 0 cc 
U 
O (3) 
ö3 
mo 
Co 
Ot 
U w- 
94 
3 
Cytoplasmic NF-xB 
Nuclear NF-xB 
Cytoplamsic IxBa 
Cytoplasmic IKB3 
Cytoplasmic licBc 
Number of genes activated 
2.5 
32 
C 1.5 
0 
c 
c1 
0 
u 
0.5 
0 
m N 
O1 
A 
01 
0.5 1 1.5 2 2.5 3 3.5 4 
time /s X 104 
Figure 5.12: Extended kinetic anaylsis following stimulation. Activation is initially as 
displayed in Figure 5.7; over time gene transcription is initiated, as shown, and resultant inhibitor 
translation results in the shut-down of the system. 
scription results in negative feedback and consequently switches the system off over a 
realistic time period. Different inhibitor isoforms are also included in the model. 
5.3.4 Pathway Equilibrium 
Not only are the dynamic properties of the system following stimulation of interest, but 
steady-state pathway behaviour is also important. Nuclear and cytoplasmic concentrations 
of NF-KB at equilibrium with changing relative levels of inhibitor are shown in Figure 5.13. 
This demonstrates that complex formation of NF-KB with IiBO causes its cytoplasmic 
retention, in close agreement with existing biological data (Figure 5.14). The results again 
verify the suitability of the model, matching well with experimental findings. 
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Figure 5.14: Localisation of NF-KB at equilibrium. The same quantitative results are 
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5.3.5 Optimum Pathway Operation with Different Inhibitor Ra- 
tios 
Investigating further the effects of different relative NF-KB to inhibitor ratios, but instead 
with regard to pathway dynamics, gives the results of Figure 5.15. The `effectiveness' of the 
pathway (here defined as the amount of nuclear translocation of NF-KB one hour following 
stimulation) is plotted against relative levels of NF-nB to I, c Ba. This demonstrates optimal 
pathway operation with a 1: 1 NF-KB: InBa ratio. This is intuitively reasonable, since too 
much inhibitor would simply hinder activation, and too little would mean that more NF- 
r-B would already be in the nucleus prior to activation (from Figure 5.13), meaning less 
would be available to translocate. 
However, this finding is at odds with quantities of inhibitor found in live cell exper- 
imentation, where three times the level of inhibitor is observed [CCDQ99]. Reasonably 
assuming that the pathway has evolved to be as effective as possible, this excess inhibitor 
must either serve some other more vital role, or somehow be held inactive in the resting 
state so as not to interfere with pathway activation, at least by cytokines. This could 
involve the cytoskeleton [CKL+97, QMPD91, QOT+94], and is investigated further in the 
following chapter. 
5.4 Review of Model 
5.4.1 Summary 
A working model of the IL-1-activated section of the intracellular NF-KB signalling pathway 
has been formulated, which has been developed from the chemical model of the previous 
chapter. The model has been verified against exisiting biological data, both following 
activation (Figure 5.7) and at equilibrium (Figure 5.13). The model has been found to 
have an appropriate dependence on its parameters (Figure 5.8), and has successfully been 
used to investigate different features of the pathway (Figures 5.9,5.10,5.11,5.12, and 
5.15). Results from the model have raised questions about the pathway, which will be 
considered further in the following chapter. 
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5.4.2 Modelling Concerns 
Although the model has been successful in its aims so far, issues and limitations in its 
capabilities must of course be considered. 
A major concern in all modelling is that reproduction of experimental data can often 
be achieved simply by fixing parameters to reflect the desired outcome. Since the NF-KB 
pathway is a complex multi-component system, this is especially true. 
This issue exists for all modelling methods, but it is perhaps less problematic with 
agent-based modelling. As it requires greater explicit input of detail than many modelling 
approaches, its operation is more tractable, and potentially incorrect details in the model 
are obvious, due both to the lack of implicit assumptions in the model and also because of 
its tangible and intuitive description of the system. Furthermore, the agent-based model 
is found to display qualitatively reasonable behaviour with a range of parameter values 
(Figure 5.8) without the same amount of `tweaking' as is often found in more accepted 
ODE models, where parameter fitting can be used to make a model `work' despite major 
flaws in its description (as with the nuclear/cytoplasmic issue of Hoffman et al. [HLSB02], 
as discussed in Section 3.3). This reflects the fact that in the agent-based model, the 
pathway is being recreated in a realistic and less abstract way, so alterations in the model 
are more likely to match alterations in the real pathway. 
While agent-based modelling requires greater descriptive detail than ODEs, the details 
can be formulated from existing understanding. For example, molecular movement rules 
can be made to duplicate Brownian motion (AB04], as implicitly assumed in ODE-based 
models anyway, and the effects of altering the rules can be easily investigated, as in Section 
4.4. The requirement for greater modelling input also provides scope to investigate different 
areas of the system, such as changing the molecular movement rules to account for fea- 
tures such as cytoskeletal transport-the agent-based model can not only duplicate ODE 
modelling, but also extend its capabilities. The greater descriptive ability is a benefit of 
agent-based modelling; while it requires more variables to be defined, any assumptions are 
explicit and can be fully investigated, which ultimately allows more details of the system 
to be explored. It is worth noting that the agent-based model requires only the same rate 
constant data as an ODE model, and other details such as movement can simply be made 
to match the implicit assumptions of ODEs if necessary, so the model is not restricted by 
lack of data any more than any other kinetic model. 
A drawback of agent-based modelling over many other modelling approaches is that 
it often requires greater computing time. In some circumstances this is not a problem, 
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but if repeated simulations of large systems are required then measures must be taken 
to ensure that the model does not become prohibitively time-consuming. The modelling 
thus far has not been hindered by this, but it is worth considering the efficiency of the 
computer code and possible parallelisation of the simulation [CSHO6], which will permit 
greater complexity in the model than might otherwise be possible. 
The agent-based model has not been used to recreate existing ODE models of the NF-KB 
pathway because this would be a rather time-consuming process-both in its formulation 
and simulation-with little benefit. There would be little to be gained scientifically from 
the exercise, and the worth of the model can be proved in other ways; in its mathematical 
formulation, comparison with existing biological results, and most importantly as a predic- 
tive tool. However, from the results of the previous chapter it would be entirely possible to 
recreate ODE models. The model has not been compared with existing ODE models be- 
cause they model different areas of the pathway over different time periods; an appropriate 
modelling method is used for the models' respective purposes. Even comparisons between 
ODE models are often hampered due to different models being fitted with different sets of 
data [LPB+061. 
The agent-based model does not aim to replace ODE or other modelling methods, but 
provides an alternative in instances where explicit spatial resolution is required, and time 
periods and numbers of molecules are sufficiently small for the simulation to be computed 
in a reasonable time. For the model to incorporate and be incorporated into other models, 
it would be useful to write it in a common language such as Ce11ML or the Systems Biology 
Markup Language (SBML). However, this is not a major aim of the model; these languages 
are unable to represent individual-based models [Wa106], and modelling should certainly 
not be restricted by this. 
It might be questioned why it is worth using a different modelling method to previous 
work. It is in fact important to try a different approach for many reasons; simply because 
other methods have been successful does not mean that they are the only or best way, nor 
the most appropriate for all parts of the system. Different approaches offer different ben- 
efits, and at least offer a different way of thinking about the system in question, requiring 
different details and raising different questions at the very least. The aim of modelling is to 
assist with understanding; this can be achieved not only through results from simulations, 
but also through the formulation of the model itself. An added benefit of using agents in 
particular is that they are intuitive and easily understood, which is useful for discussing 
the model with biologists, and also for potential future use of the model by biologists. 
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5.5 Conclusions and Further Work from Agent-Based 
Pathway Modelling 
Agent-based pathway modelling has been shown to be an appropriate and successful rep- 
resentation of the intracellular NF-, d3 signalling pathway. Results suggest that further 
investigation of relative levels of NF-, cB and IKB at equilibrium is necessary, specifically 
why there are excess inhibitors in live cells. This is the direction that modelling will take 
in the next chapter, which is appropriate both in terms of the strengths of the model, 
such as its explicit spatial resolution, and in terms of specific questions about the path- 
way that can be explored using such a model. Indeed, the focus of modelling should be 
directed by what the model can achieve, what needs explaining biologically, and what can 
be realistically verified experimentally. For example, further study of transcription would 
not be sensible within the scope of the pathway model. Instead, investigation of spatial 
phenomena, such as binding of IKB to the cytoskeleton, is both biologically relevant and 
can be easily undertaken with the agent-based model. 
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Chapter 6 
Physical Effects on Pathway 
6.1 Features to Investigate 
The previous chapter established a successful model of the NF-KB signalling pathway that 
incorporates spatial detail. Having verified its basic operation, the model can now be 
used with greater confidence to investigate the pathway further, in particular focussing on 
spatial details of its operation. Following on from the previous chapter, the model should: 
1. From the data of Figure 5.15, investigate whether excess inhibitor in the system is 
held inactive in the resting cell, and if so, how. 
2. Using the spatial resolution of the model, investigate a simple but verifiable physical 
effect on the system, namely that of the shape of the cell. 
The aim of this work is to form biologically testable predictions about the pathway in 
order to gain further insight into its operation. 
6.2 Actin Involvement in Pathway 
6.2.1 Background to Investigating Actin Involvement 
Results from the previous chapter suggest that in live cells there exist three times the 
number of inhibitor molecules than are required for optimal operation of the TIR-activated 
pathway. As mentioned, it seems that the excess inhibitor must either serve some other 
more vital role, or else must be held inactive. The latter option is both the more likely 
and the more sensible first line of investigation with the model. 
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The cytoskeleton is important to the pathway (see Section 2.4), and it is known that 
actin filaments of the cytoskeleton possess a binding site for I, cB [CKL+97]. Since pathway 
response is different following mechanical stimulation than with cytokines, it seems realistic 
that the cytoskeleton could be involved in sequestering excess IiB, which could be released 
mechanically and contribute to alternative pathway behaviour. A sensible investigation of 
how excess IKB molecules are sequestered is therefore to introduce actin filaments to the 
model to which IiB can bind. 
6.2.2 Introducing Actin Filaments to the Model 
Actin filaments are introduced to the model by defining radial lines of random direction 
that extend from the centre of the nucleus to the cell membrane, to which I, cB can bind 
in the cytoplasm (the `actin' in the nucleus is disregarded, simply being an artefact of the 
method), as depicted in Figure 6.1. This is a reasonable approximation to the biology 
described in Section 2.4. 
The model assumes an interphase cell: large-scale cytoskeletal structures are treated as 
static, hence there is no need to consider individual molecules of the structure (sufficient 
numbers of binding sites are assumed). Intermediate filaments are ignored as the physics of 
mechanical stress is not explicitly modelled. Accessory proteins are assumed to be present 
in large numbers and readily available, so need not be modelled explicitly. 
Ir, B can bind to actin in the same way as it binds to other agents: it must be within 
a defined distance of any point on the filament to be able to bind, as described in Section 
4.1.1-the filament is in effect an agent that is a line rather than a particle. Once bound 
to actin, the IKB is effectively removed from the system for the purposes of investigating 
equilibrium; reversible binding is ignored for the purposes of this investigation. 
6.2.3 Actin Binding Results 
NF-nB and InBa are allowed to reach equilibrium in the cell, both in the presence and 
absence of actin. When actin is present, InBa can not only bind to NF-r. B, but also to the 
actin filaments (see Figure 6.2). The number of actin filaments and the interaction radius 
for binding are chosen to be reasonable, as recorded in Appendix D. 
Figure 6.2 shows that the expected 1: 1 NF-, B: IiBa binding ratio is achieved with 
approximately a 1: 3 ratio of NF-KB to total IsBa in the presence of actin. This suggests 
that actin could indeed sequester excess inhibitor in the resting cell; in the absence of actin, 
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Figure 6.1: Three-dimensional visualisation of agent positions in the model in- 
cluding actin filaments. Visualisation of the cell membrane is also shown. 
the same maximum is reached at around 1: 1 NF-KB to total IkBa. 
This result is a clear and testable hypothesis from the model: namely, approximately 
two-thirds of all ItBa is bound to actin in the resting cell. Although other explanations 
exist for the earlier observations from the model (as discussed in Section 5.3.5), the combi- 
nation of existing understanding of the pathway and the model results make this a sensible 
result to validate biologically. 
6.2.4 Biological Validation of Model Results 
Experimental work was carried out by Anderson [PHS+06, And06]. Assessment of IKB- 
actin binding was performed by immunoprecipitation and Western blotting, as described 
below. 
In immunoprecipitation, an `antibody' is used to bring a corresponding protein out 
of solution [AJL+02]. The particular antibody is chosen to bind to a specific protein of 
interest. The antibody is introduced to cell extracts and incubated. A centrifuge is then 
used to draw out the specific antibody and associated protein, as shown in Figure 6.3. The 
antibody-bound proteins form a pellet at the bottom of the container. 
To assess complex formation, an antibody is chosen to bind to one of the protein 
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Figure 6.2: NF-KB-IkBa and actin-IkBo levels at equilibrium with changing NF- 
KB: IKBa ratios (NF-KB concentration constant). With actin present, the maximum 
NF-AKB-IKBo complex level is reached at around 1: 3 NF-KB: IkBa concentration (black line), 
with the excess IKBce bound to actin (blue line). The same maximum is reached at around 1: 1 
concentration in the absence of actin (green line). 
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Figure 6.3: Schematic diagram of immunoprecipitation. (i) Proteins A and B, and 
A-B complexes are present in solution, with A bound to its antibody. (ii) A proteins (bound to 
their antibody) are separated by a centrifuge. (iii) The remaining solution is removed, with B 
antibody introduced. (iv) B proteins (bound to their antibody) are separated by a centrifuge. 
To determine molecular concentrations, the resulting pellets in (ii) and (iv) are dissolved and 
separated by electrophoresis before Western blotting (see Figure 6.4). 
components of interest (protein A, say, in an A-B complex). The relative complex formation 
of B with A can he found by using a second antibody to bring out of solution the remaining 
B proteins. This is performed only on the remaining solution (or `supernatant') following 
the first immunoprecipitation. 
The pellets are then dissolved and the molecules separated in each by electrophoresis 
to determine protein concentrations, as shown in Figure 6.4. Here, an electric current is 
applied to the mixtures, and the proteins are transported a distance along a gel dependent 
on their mass and charge. The relative levels of complexed and uncomplexed proteins can 
be determined by the relative stain intensities, as observed by a process called Western 
blotting (results shown below). 
Results 
The above procedure was performed with actin as `protein A' and IicBa as `protein B'. 
The results of a Western blot is shown in Figure 6.5. Only IKBa is stained for. Biological 
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Protein A 
Protein B 
Figure 6.4: Schematic diagram of electrophoresis. Following separation of the solution 
in Figure 6.3, A and A-B complexes are in one column (labelled A+B), and B proteins in a 
second column. Relative levels of complexed and uncomplexed B proteins can be determined by 
the relative stain intensities in the two columns. A Western blot is used to observe this (procedure 
not described). 
results agree with the quantitative predictions of the model. 
6.2.5 Conclusions of Actin Binding 
Based on preliminary modelling results and existing knowledge of the pathway, a mech- 
anism for sequestering the apparent excess inhibitor in the inactive pathway has been 
successfully hypothesised with the model; subsequent experimental work has supported 
this. 
Although the same investigation of actin binding could he performed using ODEs, with 
actin binding a first-order reaction, this would be less realistic and more restricted in what 
could be observed; it is also unlikely that the question of excess inhibitor would have even 
been raised using ODEs. ODE models tend to initialise the system by allowing NF-kB to 
cause transcription of IKB until equilibrium is reached; results in this chapter demonstrate 
that this does not produce physiological levels of inhibitor unless actin is included in the 
model, either explicitly or implicitly. Although it does not invalidate ODE models-the 
excess inhibitor is treated as inactive anyway-----it is something that would most likely not 
be predicted without a new modelling approach. 
Only I, cBa was included in the model since it is the most critical isoform, it is repre- 
sentative of other isoforms, and is experimentally verifiable. 
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Figure 6.5: Immunoprecipitation of actin (left column) and secondary IkBa im- 
munoprecipitation (right column). Cell extracts were subjected to a first immUnoprecip- 
itation using an actin antibody (left column), followed by a second immunoprecipitation using an 
Ir, Ba antibody (right column). Detection is by a Western blot; I, cBa is observed in each column, 
with the left column showing the amount of actin-bound IKBa, and the right column the amount 
of remaining IºcBa. Graphing the stains shows an approximately 2: 1 ratio of actin-bound IKBa 
to free Irffla, corresponding to a 1: 1 NF-nB: free IrcBa ratio given a 1: 3 NF-KB: total IrcBa ratio, 
as predicted by the model. One of three experiments is shown. 
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6.3 Effect of Cell Shape on Pathway 
6.3.1 Aims of Cell Shape Investigation 
The effect of the shape of the cell on pathway operation is a relatively simple but significant 
line of investigation. Several factors affect the shape of the cell, which themselves also affect 
the pathway for reasons other than just the resultant cell shape, such as the activity of 
related pathways. It would therefore be impossible to investigate the effect of cell shape 
experimentally in isolation; using the model to isolate the physical effects is therefore 
doubly valuable. For example, in some cell types, differentiated cells (cells that can no 
longer divide) have a greater aspect ratio, but other apects of the signalling pathway may 
also be affected [Wal06]. 
The model will be used to establish if and how cell shape affects the pathway, or whether 
it is simply incidental to pathway operation. A very simplified representation of cell shape 
will be used to investigate this initially (Section 6.3.2), followed by forming a means to 
realistically compare this with live cell data (Section 6.3.3). 
6.3.2 Cuboids with Different Aspect Ratios and Volumes 
A simple representation of cell shape is appropriate in order to establish its effect on the 
pathway. To achieve this, a cubic nucleus is surrounded by a cuboid-shaped cytoplasm, 
with the x-length of the cell membrane the parameter of interest (see Figure 6.6). The 
nucleus is of fixed size and held at the centre of the cell; the cell membrane has a fixed 
square cross-section in the y-z plane, and varies from equal length (cubic) to ten times the 
length in the x-direction. Cytoplasmic concentrations of molecules are held constant with 
different cell shapes, hence more molecules are present in larger cells. 
The pathway is activated by IL-1 as previously, and the time taken for nuclear import 
of NF-KB to begin following stimulation is observed with different x-lengths of the cell 
(Figure 6.7). An apparent linear dependence of this delay on the distance of the receptors 
to the nucleus is observed, which is reasonable since the signal has further to travel. This 
demonstrates a simple observable effect of the shape of the cell on the pathway. Although 
a fairly elementary observation, it helps establish the importance to the pathway of cell 
shape, and is not necessarily immediately obvious since although the signal has further to 
travel, the concentration of molecules is held constant with larger cells in the simulations, 
which could have countered the increase in distance to travel. 
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Figure 6.6: Image of cuboid-shaped cell. Cuboid-shaped cell with NF-KB and I, B shown. 
Different aspect ratios of the cell are achieved by keeping two dimensions fixed and varying the 
third dimension (the x-axis, say, indicated by arrows in the diagram), with the nuclear dimensions 
fixed and maintained at the centre of the cell, as shown. TIßs (shown as asterisks) arc present 
only at the 2 varying ends of the cell to isolate the effect of changing the aspect ratio. 
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Figure 6.7: Delay following stimulation for NF-nB nuclear transport to begin 
with differently lengthed cells. With TIlts closer to the nucleus, the time delay between 
stimulation and nuclear transport is small, and increases fairly linearly with increasing distances. 
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Figure 6.8: Amount of nuclear translocation of NF-KB one hour following stim- 
ulation of cells with varying aspect ratios. With TIl3s closer to the nucleus, nearly 
half the NF-nB translocates within one hour, decreasing almost exponentially with increasing 
distances (solid line). The same effect is observed with total NF-, cB translocation (dashed line), 
demonstrating that this is not a consequence of nuclear receptors limiting translocation (see text). 
In the same virtual experiment as above, the fraction of NF-KB located in the nucleus 
one hour following stimulation is observed (Figure 6.8, solid line). This shows a near- 
exponential decrease in nuclear localisation with increasing x-lengths of the cell. The total 
amount of NF-, cB localised in the nucleus following one hour is also plotted (Figure 6.8, 
dashed line) to confirm that this is an effect of the change in cell shape rather than an 
artefact of increased numbers of molecules in larger cells. If this were the case, the total 
level of NF-i B in the nucleus would remain constant due to nuclear import restricting 
import; since this is not so, the effect can be reasonably attributed to the shape of the 
cell. As opposed to the linear relation seen previously, the exponential dependence here 
is likely due to the accumulation of the increased delay for nuclear translocation over the 
hour-not just for translocation to begin. 
It has been established that cell shape has an observable effect on the pathway in the 
simulation, not only on the time taken for activation to affect nuclear translocation of 
NF-nB, but perhaps more significantly also on the level of nuclear translocation of NF- 
112 
nB. These results clearly require validation, and although biological experiment cannot 
replicate the method in the stimulation, some kind of comparison should be possible. 
Notable is the dependence of the pathway not only on the shape of the cell but also 
on the distribution of surface receptors; in the simulation, receptors are present only at 
the `far' ends of the cell to emphasise the effect of the shape of the cell, so the modelled 
effects may be an over-estimation. It should also be noted that the model cuboid cell is a 
particularly crude representation that should be improved upon, particularly with regards 
to biological validation, as performed in the following section. 
6.3.3 Cell Morphing 
To enable closer comparison with biological results, a realistic representation of cell shape 
in the simulation is desirable. Although it is not possible to eliminate the effects of the 
various other parameters that affect the pathway, having a close match to the actual shape 
of a cell in the simulation would permit a much fairer comparison, and would be a suitable 
direction for future work to take. 
A toolkit exists for Matlab that can morph any geometric shape onto any three- 
dimensional object (the object being a collection of images, which are a `z-stack' of slices 
through the real object) [WooO5]. The software was originally designed for exploring 
the biomechanics of the knee, mapping a known topology onto specific knee scans. The 
same principle can be used in modelling intracellular pathways, mapping the model cell 
from a known geometry (which permits straightforward boundary collisions) to a three- 
dimensional representation of a real cell. Thus real cell shapes can be modelled, at each 
iteration performing a reverse transformation on the `real'-shaped cell to check for bound- 
ary collisions of molecules (Figure 6.9). This provides a basis for closer comparison of the 
model with biological experiment in the future. 
6.3.4 Conclusions of Cell Shape Effects 
Simulation has shown that cell shape can directly affect pathway operation, both in terms 
of the time' taken for nuclear translocation of NF-KB to begin, and in the quantity of 
NF-KB translocation. Important to these observations is not only the shape of the cell 
but also the distribution of surface receptors; this adds to the difficulty of biologically 
validating the results of the model. However, such a validation should be possible to a 
certain extent; to assist with this the model has been developed to replicate the shapes of 
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Figure 6.9: Three-dimensional image of model cell with membranes defined by 
confocal images of real cell. Morphing program [Woo05] can define cell shape from a 
`z-stack' of confocal images, and permits consideration of boundary collisions of molecules in a 
simulation. Confocal images used with kind permission from Fang Zhao, Advanced Microscopy 
Unit of the Haartman Institute, University of Helsinki [Zha05]. 
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real cells, permitting a more direct comparison between simulation and experiment. 
6.4 Diffusion Concerns 
Investigation of cell shape has produced predictions about the translocation times of 
molecules, though these do not necessarily agree with diffusion equations. Although pre- 
viously assumed not to be of vital importance to the model in Section 4.1.2, in light of the 
above modelling results this should be reviewed. 
Molecules move around the cell due to continual random thermal motions known as 
diffusion [Ber93, BR93, JD83]. The average kinetic energy E of the motion in each axis of 
a particle at temperature T is given by: 
E= kT/2 (6.1) 
where k is Boltzmann's constant [Ber93]. 
Considering just one axis, then given a particle of mass m, the average velocity <v> 
along that axis can be calculated by incorporating Equation 6.1 into the kinetic energy 
equation E= mv2/2 and rearranging to give: 
< v2 >= kT/m (6.2) 
giving a root-mean-square velocity of: 
< v2 >1/2= (kT/m) 1/2 (6.3) 
Thus, from Equation 6.3, the instantaneous velocity of a particle can be estimated 
from its mass and temperature. Given that NF-s' B is found to have a molecular mass of 
approximately 50kilodaltons [RBW+90], then at body temperature of 310K, it would travel 
at around 7ms-1--several-fold larger than assumed in the model. However, the migration 
of molecules depends on their random motion, not just their kinetic energy; this aspect of 
the movement rules must also be considered. 
Constant collisions mean that each molecule is forever changing direction. Given the 
randomness of changes in direction, then if a group of molecules starts at length x=0 at 
time t=0, their root-mean-square position at time t is given by: 
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< 22 >1/2= (2Dt)1/2 
(6.4) 
where D is known as the coefficient of diffusion, and is a measure of the migration of a 
particular type of molecule in a particular medium [Bcr93]. 
It is evident from Equation 6.4 that the displacement of molecules is proportional to 
the square-root of time, in contrast to the linear results of Figure 6.7. 
For a small molecule in water at room temperature, D 10-9m2s-1. Thus to traverse 
the length of a cell of diameter 10-5 would take approximately 0.05s-many times faster 
than in the model. This estimation of the movement of a typical molecule inside a cell 
has again highlighted problems in the movement rules of the model; both the speed and 
motion of molecules in the model have been shown to be inaccurate and the consequences 
of this must be noted. 
Although many results from the model do not rely on spatial detail, and the results of 
Section 4.4 still largely hold, the problems raised here are clearly critical flaws for physical 
modelling, with molecules in reality traversing the diameter of the cell several times over 
in the time steps used for simulation. 
Given the much larger speed of molecules than previously assumed, spatial resolution of 
the model could be drastically improved-recall Equation 4.15-though this would require 
the use of a far smaller time step, in accord with Equation 4.14. Thus, although larger time 
steps can still be used in the model to give macroscopically correct results, at the time 
steps used in the simulations which yield reasonable execution times, spatial resolution 
would be far more limited than assumed until now. 
While the limitations of the movement rules in the model do not invalidate all modelling 
results, they must be re-considered to draw further conclusions on spatial detail. 
6.5 Conclusions of Spatial Modelling 
The first consideration of spatial detail in the NF-KB pathway has produced a quanti- 
tatively validated prediction about the involvement of actin in the inactive cell, as well 
as qualitative predictions about the effect of cell shape on nuclear translocation of NF- 
0. The movement rules of molecules would have to be re-considered to permit further 
investigation of spatial detail. 
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Chapter 7 
Conclusions and Future Work 
7.1 Summary of Achievements 
The thesis has achieved the following: 
1. The biology of the NF-KB signalling pathway has been outlined, and different mod- 
elling approaches have been identified. Based on their various advantages and disad- 
vantages, the most appropriate approach has been selected for the purpose of gaining 
new insight into the pathway, incorporating spatial and stochastic detail. 
2. The model has been successfully verified at a chemical and pathway level. 
3. The model has been used to investigate pathway operation, with predictions formu- 
lated and tested. 
Further consideration of the modelling method follows. 
7.2 Review of Modelling 
An agent-based modelling approach has been chosen to model the NF-KB pathway due 
both to its suitability in representing the pathway and its ability to investigate areas of 
the pathway that are often abstracted away in existing models, such as spatial details. 
The model has succeeded in its functional requirements: it is extensible, sufficiently 
flexible to incorporate abstractions where necessary, provides a clear visualisation of the 
pathway, is based on mathematical structures that can be investigated in detail, and has 
scope to be manipulated by biologists. Agent-based modelling has not only provided novel 
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results due to its different approach to modelling the NF-r. n signalling pathway, but also 
due to the new questions it raises in its formulation. 
No model can ever provide a complete description of the system it seeks to recreate 
(indeed, the aim of modelling is not to do this, but simply to understand better the system 
as straightforwardly as possible), but it is desirable that details can be added or removed 
from the model as necessary to model different features of the system. This is very true of 
the agent-based model, where, for instance, molecular movement rules or binding details 
can be changed as required without altering the rest of the model, permitting as much or 
as little detail as is needed. 
The agent-based modelling approach not only has its own benefits, but also overcomes 
many of the problems of widely-accepted reaction kinetics models. While many of these 
issues are not inherent to reaction kinetics modelling, but rather its execution, they must 
still be addressed. Spatial considerations are essential to properly model the NF-KB sig- 
nalling pathway due to its susceptibility to mechanical stimulation [KOTSO41; this cannot 
be understood by simply using reaction kinetics. Another spatial issue is that of transport 
of molecules between the cytoplasm and nucleus, with the differing volumes of each com- 
partment sometimes being neglected with concern to their effects on concentration. Time 
delay in transcription is a further complication that is often not given proper considera- 
tion, but is easily incorporated with agents. Agent-based modelling can provide a more 
tangible view of what is occurring in the pathway, incorporating spatial considerations and 
allowing detailed observation of specific mechanisms in the pathway. Although agent-based 
modelling has its own drawbacks, its advantages make it a useful complement to existing 
models. 
7.3 Review of Results 
Results from chemical interaction modelling in Chapter 4 demonstrate a sound basis for 
pathway modelling. Initial results from pathway modelling in Chapter 5 establish the model 
as a good representation of the NF-KB signalling pathway. Further investigation raises an 
issue about excess inhibitor molecules in the pathway. Results in Chapter 6 provide a 
prediction about this issue, which is experimentally validated. Further modelling work 
demonstrates an observable effect of the shape of the cell on the pathway, though this also 
reveals limitations of the model as it stands. 
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7.4 Future Work 
Obvious further work to the model would be to continue investigating the effect of cell 
shape with the real cell images, and comparing this with experimental results. This would 
require further collaboration with experimental cell biologists, as well as a review of the 
movement rules. A progression of this in the model would be to begin modelling mechanical 
stress and mechanical stimulation, although this would be a major undertaking. 
Much of the modelling of the NF-nB pathway has used approximations and estimates of 
chemical rate constants; indeed, this was part of the motivation to use agents rather than 
an ODE model, since rate constant data is often rather unreliable. The model could be 
used in the future to investigate this further, for example to check or suggest rate constant 
data by comparing expected behaviour with model results using different rate constants. 
Unlike many other models of the NF-nB pathway, the thesis has not concentrated 
much on transcription and translation of molecules. This is because it was found that 
there was much to investigate aside from transcription which was more appropriate and 
achievable in the model. Future work could investigate transcription and translation in 
greater detail, making use of the stochasticity and time delays in the model, although work 
may be hampered by lack of biological data. Interactions of the NF-KB pathway with other 
pathways and with other cells would also be a constructive line of investigation. 
Although agents have been used to model the NF-KB pathway, their potential has not 
necessarily been fulfilled, though this would be near impossible, and the most has been 
made of available information in terms of molecular data and biological results against 
which to verify the model. Agents have prompted original findings about the pathway and 
a different approach to biochemical modelling. Future work could clearly expand upon 
this, whether at the small scale with increased spatial and temporal detail, or in terms of 
increased biological complexity, both in pathway component detail and effects on and from 
other pathways. 
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Appendix A 
Two-Particle Chemical Interaction 
Matlab Code 
'I. Chemicals A and B inside a cubic box of side length L 
y. A interacts with B 
'/. Have matrix for each molecule of: 
% time of event 
'h unbound 
% bound 
clear statematrix_A 
clear statematrix_B 
'h constants 
dt = 1; 7. time step 
t= dt; % current time 
t_stop = 150; % length of simulation 
speed = 5.9e-7 % average speed of particle (ms"-1) 
speed-range = le-8; % maximum possible deviation from the average speed (ms"-1) 
angle-range = pi/10; % maximum possible deviation from current direction (radians) 
concentration_A = 50e-9; % concentration of A in molars 
concentration_B = 30e-9; % concentration of B in molars 
L= 3e-6; % box side length L metres 
total_A = round(6.02e26*concentration_A*L"3); 
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initial number of A molecules (it is 10"26 not 10"23 to account for use of m"3 not dm"; 
total_B a round(6.02e26*concentration_B*L"3); '/. initial number of B molecules 
kab a 1e6; '/. rate constant of a and b association 
threshold_A_B - ((3*kab*dt)/(4e3*pi*6.02e23))"(1/3); % interation radius 
initial positions 
A= zeros(3*total_A, 1); 
'/, This is all the A molecule matrices (there are 3 rows for each A molecule matrix) 
A(3*(O: total_A-1)+2) = 1; % putting free cytoplasmic label to each A molecule 
x_A(1: total_A, 1) = L*rand(total_A, 1); hx position 
y_A(1: total_A, 1) = L*rand(total_A, 1); '/ y position 
z_A(1: total_A, 1) = L*rand(total_A, 1); '/, z position 
B= zeros(3*total_B, 1); 
B(3*(O: total_B-1)+2) = 1; 
x_B(1: total_B, 1) - L*rand(total_B, 1); 
y_B(1: total_B, 1) = L*rand(total_B, 1); 
z_B(1: total_B, 1) = L*rand(total_B, 1); 
a= ones(total_A, i); % counter for each A molecule 
b= ones(total_B, 1); % counter for each B molecule 
boundindexA = zeros(total_A, 1); % index of the B molecule to which each A is bound 
boundindexB = zeros(total_B, 1); '1. index of the A molecule to which each B is bound 
'/ Simulation 
while t <= t_stop 
for n=1: total_A 
if A(3*(n-i)+2, a(n)) _= 1%A molecule is free in cytoplam 
for p=i: total_B 
busy-B(p) = B(3*(p-1)+2, b(p)) - 1; '/. used to see if B is busy 
end 
Looking to bind (from perspective of each A molecule) 
position_matrix_with_B - [x-A(n) - x_B, y_A(n) - y_B, z_A(n) - z_B]; 
% difference in x, y, z coordinates between 'n'th 'A' agent and each 'B' agent 
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distance_matrix_with_B 
[(position_matrix_with_B(1: total_B, 1)). 02 + 
(position_matrix_with_B(1: total_B, 2)). 02 
+ (position_matrix_with_B(1: total_B, 3)). "2]; 
% squared distance between 'n'th A and each B 
%(squared distance is used to determine interaction) 
temp - find(distance_matrix_with_B -- 0); 
% preventing division by zero 
% (temp is used as a temporary matrix for various purposes) 
distance-matrix-with-B(temp) - 0.000001; 1 preventing division by zero 
decision_matrix_with_B - rand(total_B, 1). /distance-matrix-with-B; 
% inroducing randomness to the decision of interaction, 
I decreasing with the square of the distance 
temp a find(distance_matrix_with_B > threshold_A_B"2); 
'/. finding the indices of 'B' agents 
'/. too distant to interact with the 'n'th A agent 
decision-matrix-with-B(temp) - 0; 
% marking 'B's too distant to interact. 
% Entry not deleted as this ruins indices. 
temp = find(busy_B "= 0); 
I agent 'B' is unavailable if the 'busy' matrix entry isn't zero 
decision-matrix-with-B(temp) - 0; % marking the 'B' agents that are unavailabl, 
% choose the best 
index_best_B s find(decision_matrix_with_B -- max(decision_matrix_vith_B)); 
% the index of the 'best' 'B' molecule 
index_best_B - index_best_B(1); 
7.. the (1) means that if there are multiple equal candidates 
'/. (likely if they're all marked as unavailable) then the method still works 
best_B = decision_matrix_with_B(index_best_B)/threshold_A_B; 
decision - [best_B index_best_B]; 
'/. outputting the 'decision number' and 'B' index 
j- decision(2); 
if decision(1) >0 
a(n) - a(n) + 1; 
b(j) = b(j) + 1; 
A(3*(n-1)+1, a(n)) - t; 
B(3*(j-1)+1, b(j)) = t; 
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A(3*(n-i)+2, a(n)) a -i; '/. no longer free 
B(3*(j-1)+2, b(j)) - -1; 
A(3*(n-1)+3, a(n)) - 1; bound 
B(3*(j-1)+3, b(j)) - 1; 
boundindexA(n) - j; 
V. inputting matrix index of molecule with which it is bound 
boundindexB(j) - n; 
end 
end 
end 
% movement 
for n-1: total_A 
theta_vec_A - -pi + 2*pi*rand(total_A, 1); '/. random angle 
phi_vec_A - -pi + 2*pi*rand(total_A, 1); % random angle 
r_vec_A a speed + (-speed_range+2*speed_range*rand(total_A, i)); 
% random speed within speed range of average speed 
(x_vec_A, y_vec_A, z_vec_A] - sph2cart(theta_vec_A, phi_vec_A, r_vec_A); 
'/. converting velocity vector to Cartesian 
x_A(n) = x_A(n) + dt*x_vec_A(n); 
'h assigning the new position in Cartesian coordinates 
y_A(n) = y_A(n) + dt*y_vec_A(n); 
z_A(n) = z_A(n) + dt*z_vec_A(n); 
if x_A(n) >L 'h i. e. molecule is outside box 
x_A(n) = 2*L - x_A(n); 
x_vec_A(n) _ -x_vec_A(n); 
V. reversing the stored direction to account for the collision 
(theta_vec_A(n), phi_vec_A(n), r_vec_A(n)] 
= cart2sph(x_vec_A(n), y_vec_A(n), z_vec_A(n)); 
end 
if x_A(n) <0%i. e. molecule is outside box 
x_A(n) -- x_A(n); 
x_vec_A(n) - -x_vec_A(n); 
[theta_vec_A(n), phi_vec_A(n), r_vec_A(n)] 
cart2sph(x_vec_A(n), y_vec_A(n), z_vec_A(n)); 
end 
if y_A(n) >L 'I. i. e. molecule is outside box 
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y_A(n) - 2*L - y_A(n); 
y_vec_A(n) - -y_vec_A(n); 
(theta_vec_A(n), phi_vec_A(n), r_vec_A(n)] 
- cart2sph(x_vec_A(n), y_vec_A(n), z_vec_A(n)); 
end 
if y_A(n) <0%i. e. molecule is outside box 
y_A(n) -- y_A(n); 
y_vec_A(n) - -y_vec_A(n); 
[theta_vec_A(n), phi_vec_A(n), r_vec_A(n)] 
- cart2sph(x_vec_A(n), y_vec_A(n), z_vec_A(n)); 
end 
if z_A(n) >L%i. e. molecule is outside box 
z_A(n) - 2*L - z_A(n); 
z_vec_A(n) - -z_vec_A(n); 
[theta_vec_A(n), phi_vec_A(n), r_vec_A(n)] 
cart2sph(x_vec_A(n), y_vec_A(n), z_vec_A(n)); 
end 
if z_A(n) <0%i. e. molecule is outside box 
z_A(n) -- z_A(n); 
z_vec_A(n) a -z_vec_A(n); 
[theta_vec_A(n), phi_vec_A(n), r_vec_A(n)] 
cart2sph(a_vec_A(n), y_vec_A(n), z_vec_A(n)); 
end 
end 
for na1: total_B 
if B(3*(n-1)+3, b(n)) _= 1 
x_B(n) - x_A(boundindexB(n)); 
y_B(n) = y_A(boundindexB(n)); 
z_B(n) - z_A(boundindexB(n)); 
else 
theta_vec_B - -pi + 2*pi*rand(total_B, 1); 
phi_vec_B - -pi + 2*pi*rand(total_B, 1); 
r_vec_B = speed + (-speed_range+2*speed_range*rand(total_B, 1)); 
[x_vec_B, y_vec_B, z_vec_B] a sph2cart(theta_vec_B, phi_vec_B, r_vec_B); 
x_B(n) - x_B(n) + dt*x_vec_B(n); 
V. assigning the new position in Cartesian coordinates 
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y_B(n) - y_B(n) + dt*y_vec_B(n); 
z_B(n) = z_B(n) + dt*z_vec_B(n); 
if x_B(n) >L%i. e. molecule is outside box 
x_B(n) - 2*L - x_B(n); 
x_vec_B(n) - -x_vec_B(n); 
% reversing the stored direction to account for the collision 
[theta_vec_B(n), phi_vec_B(n), r_vec_B(n)] 
= cart2sph(x_vec_B(n), y_vec_B(n), z_vec_B(n)); 
end 
if x_B(n) <01i. e. molecule is outside box 
x_B(n) -- x_B(n); 
x_vec_B(n) - -x_vec_B(n); 
[theta_vec_B(n), phi_vec_B(n), r_vec_B(n)] 
= cart2sph(x_vec_B(n), y_vec_B(n), z_vec_B(n)); 
end 
if y_B(n) >L7. i. e. molecule is outside box 
y_B(n) = 2*L - y_B(n); 
y_vec_B(n) _ -y_vec_B(n); 
[theta_vec_B(n), phi_vec_B(n), r_vec_B(n)) 
= cart2sph(x_vec_B(n), y_vec_B(n), z_vec_B(n)); 
end 
if y_B(n) <0 '/, i. e. molecule is outside box 
y_B (n) _- y_B (n) ; 
y_vec_B(n) _ -y_vec_B(n); 
[theta_vec_B(n), phi_vec_B(n), r_vec_B(n)] 
- cart2sph(x_vec_B(n), y_vec_B(n), z_vec_B(n)); 
end 
if z_B(n) >LY. i. e. molecule is outside box 
z_B(n) - 2*L - z_B(n); 
z_vec_B(n) _ -z_vec_B(n); 
[theta_vec_B(n), phi_vec_B(n), r_vec_B(n)] 
= cart2sph(x_vec_B(n), y_vec_B(n), z_vec_B(n)); 
end 
if z_B(n) <01i. e. molecule is outside box 
z_B(n) _- z_B(n); 
z_vec_B(n) - -z_vec_B(n); 
[theta_vec_B(n), phi_vec_B(n), r_vec_B(n)] 
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- cart2sph(x_vec_B(n), y_vec_B(n), z_vec_B(n)); 
end 
end 
end 
Y. visualisation 
for n-i: total_A 
if A(3*(n-i)+2, a(n)) _= i 'I, unbound 
plot3(x_A(n), y_A(n), z_A(n), 'g. ') 
hold on 
end 
end 
for n=1: total_B 
if B(3*(n-1)+2, b(n)) _= 1% unbound 
plot3(x_B(n), y_B(n), z_B(n), 'b. ') 
else % bound 
plot3(x_B(n), y_B(n), z_B(n), 'bo') 
end 
end 
hold off 
axis([O L0L0 L]) '/ makes all axes run from 0 to L 
daspect([1 1 1]) 1 makes all axis the same scale 
drawnow 
tt+dt; 
end 
'/ finding molecular levels with time 
'/ A 
temp = 0; 
'h temp is used to put the 'arriving' matrix at the end of statematrix_A 
for n=i: total_A 
'h putting matrices that are on top of one another (in matrix 'A') next to each other 
statematrix_A(1: 3, (temp+l): (temp+a(n))) - A((3*n-2): 3*n, 1: a(n)); 
'/, this puts the matrices alongside each other without including the zero matrices 
temp = length(statematrix_A); 
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temp is used to add the next matrix at the end of statematix_A 
end 
statematrix_A - (sortrows(statematrix_A'))'; Y. putting statematrix_A in chronological order 
number_of_A cumsum(statematrix_A(2,: )); % giving number of free A at each timestep 
number_of_AB = cumsum(statematrix_A(3,: )); % giving number of bound A to B at each timestep 
B 
temp = 0; 
for n=1: total_B 
statematrix_B(i: 3, (temp+1): (temp+b(n))) - B((3*n-2): 3*n, 1: b(n)); 
temp = length(statematrix_B); 
end 
statematrix_B = (sortrows(statematrix_Bi))I; 
number_of_B = cumsum(statematrix_B(2,: )); 
number_of_BA = cumsum(statematrix_B(3,: )); 
'/. giving number of bound B at each timestep (this should equal the number of bound A) 
% Graphing molecular levels against time 
figure 
plot(statematrix_A(1,: ), number_of_A/(6.02e26*L"3), 'k: ') 
'h concentration of free A with time 
hold on 
plot(statematriu_B(1,: ), number_of_B/(6.02e26*L"3), 'k-. ') 
y. concentration of free B with time 
plot(statematrix_A(i,: ), number_of_AB/(6.02e26*L'3), 'k-') 
'/. concentration of bound A to B with time 
hold off 
title('Concentration of Chemicals against Time') 
xlabel('time /s') 
ylabel('concentration') 
legend('a', W. 'c') 
end 
127 
Appendix B 
Membrane Movement Matlab Code 
constants 
total_A = 100; 'h number of agents 
dt = 0.5; % time step 
t_stop = 200; '/, length of simulation 
r_nuc = 4000; ' membrane radius 
nuc_speed_ave = 20; % average speed of agents 
nuc_speed_range = 5; ' maximum possible deviation from average speed at each time step 
nuc_ang_speed_ave = nuc_speed_ave/r_nuc; % converting to angular average speed 
nuc_ang_speed_dev = nuc_speed_range/r_nuc; % converting to angular speed deviation 
nuc_ang_dev = pi/10; 
nuc_ang_speed = 500000/r_nuc; 
memb_calc = (2.0*r_nuc*sin(i/(2*r_nuc)))"2; 
% square of Idisplacementi between two points that are 1 unit apart on the surface 
alpha = 1.0/r_nuc; I angle between 2 points on membrane that are 1 unit apart 
% initial positions 
theta = -pi + 2*pi*rand(1, total_A); % theta coordinates of agents 
phi = -pi + 2*pi*rand(1, total_A); % phi coordinates 
r= r_nuc*ones(1, total_A); '/, r coordinates 
[x, y, z] = sph2cart(theta, phi, r); % converting to Cartesian 
% initial directions 
for n=i: total_A 
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length-test = memb_calc + 1; 
% arbitrary number larger than memb_calc for the while loop to work 
while(length_test > memb_calc) 7. while movement angle 
is too large 
theta_mov_temp =-0.5*alpha + alpha*rand(1); 
y, a random angle within permitted range 
theta-temp = theta(n) + theta_mov_temp; % move the agent through this angle 
phi_mov_temp =-0.5*alpha + alpha*rand(1); 
%a random angle within permitted range 
phi-temp = phi(n) + phi_mov_temp; 
'/. move the agent through this angle 
[temp_x, temp_y, temp_z] = sph2cart(theta_temp, phi_temp, r(n)); 
% converting new positions to Cartesian 
length-test = (temp_x - x(n))"2+(temp_y - y(n))"2+(temp_z - z(n))"2; 
% testing if the movement angles that have been generated are too large 
I (think of a circle inside a square of equal diameter; need movement to 
% be within the circle and not in the corners of the square) 
end 
theta_mov(n) = theta_mov_temp; % storing acceptable angles 
phi_mov(n) = phi_mov_temp; 
end 
'/. simulation 
for t= dt: dt: t_stop 
ang_change = 2. *rand(i, total_A)-nuc_ang_dev. *ones(i, total_A); 
theta-temp = theta + theta_mov + ang_change; 
phi-temp = phi + phi_mov - ang_change; 
mov_nucrec 
= nuc_ang_speed_ave - nuc_ang_speed_dev + 2.0*nuc_ang_speed_dev*rand(1, total_A); 
theta = theta + dt*mov_nucrec. *(theta_temp - theta); 
phi = phi + dt*mov_nucrec. *(phi_temp - phi); 
[x, y, z] = sph2cart(theta, phi, r); 
plot3(x, y, z, '. ') 
axis equal 
axis off 
drawnow 
end 
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Appendix C 
Generic description of agent-based 
algorithm 
This `pseudo-code' supplements the descriptions in the thesis of the workings of the model, 
particularly movement rules (Sections 4.1.2 and 5.1.3), interaction of agents (Sections 4.1.1 
and 5.1.2) and running the model (Section 5.1.4). 
//define parameters 
input time end 
input time step 
input cell radius 
input nuclear radius 
input quantities of each agent type 
input rate constants for possible interactions (and thus calculate interaction radii) 
input agent speeds 
set each agent to unbound state 
assign random positions of agents according to their confines (in cytoplasm 
or appropriate membrane) 
assign random direction vector for movement of each agent 
//run simulation 
for time = t_0, t_O+time_step, ..., time-end 
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//calculate possible interactions in randomised order 
[for all interaction pairs, say species A and B, one type (A) is arbitrarily chosen 
to 'seek' interaction with the other (B); interaction is not sought twice. Call the 
ones chosen to seek interaction as 'interacting-types'] 
for all interacting-types [in randomised order] 
for m= agent-1, agent-2, ..., agent-number-of-agent-type 
[e. g. all 'A' molecules] 
find distances between `m'th agent and all agents with which it can interact 
[i. e. agents which are able to interact and are in an appropriate state] 
if distances are found that exist within the appropriate interaction radius 
[call this list of distances 'dis'] 
dis-squared - square of each element of dis 
rand - vector of random numbers [length equal to length of dis-squared) 
candidates = rand/dis-squared 
[Note: this is physically unrealistic, and is used simply to decide 
which agent should interact if more than one interaction is possible. 
If this program were used in future work, this step should be replaced 
by a random decision. It is, however, a relatively rare occurence, 
and its effects small. ] 
1= find maximum(candidates) [i. e. agent 1 is chosen to interact 
(its agent type and index is tracked throughout calculations)] 
update states such that 'm'th agent is bound to 11'th agent 
end 
end 
end 
//perform movement rules 
for all agent types 
for m- agent-1, agent-2, ..., agent-number-of-agent-type 
if `m'th agent is either free or designated to 
be the interacting-type in a complex 
deviate within pre-defined boundaries from existing movement vector 
update movement vector 
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move m along vector 
if agent outside confines (such as cytoplasm) 
reverse movement vector component along radial line of cell 
reflect agent position radially over boundary 
end 
if 'm'th agent is bound to another agent (1, say) 
copy `m'th agent position as '11th agent position 
end 
else leave new position to be calculated by agent it is bound to 
end 
end 
end 
//graph data 
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Appendix D 
Parameter values used in simulations 
Unless otherwise marked in the text, the numbers of agents are scaled down in simulations 
from the following: 
number of NFkB = 60000 
number of IkBa = 60000 (subject to discussion in text) 
number of surface receptors = 10000 
number of importing nuclear receptors = 6000 
number of exporting nuclear receptors = 6000 
number of actin filaments (where included) = 8000 
Interaction radii are calculated from the rate constant values included in the supplementary 
material of Hoffman et al. [HLSB02], namely: 
NFr,. B-IKBa association =5x 105M-1s"1 
NF, cBI, cBa-IKK association = 1.85 x 105M-1s-1 
ItBa-IKK association = 2.25 x 104M-'s-1 
IKKK-IKK association =5x 105M-1s-1 (estimated-not treated by Hoffmann et al. ) 
IicBa-actin association =5x 105M-1s-' (estimated-not treated by Hoffmann et al. ) 
NFiB-importing nuclear receptor association =9x 10-Is-1 
NFiB-exporting nuclear receptor association =8x 10'5s-1 
IKBa-importing nuclear receptor association =3x 10'4s'1 
I'Ba-exporting nuclear receptor association =2x 10-4s-1 
(import and export rates depend on the number of receptors in the agent model for all 
receptor rate constants, since they are expressed in terms of a total rate as opposed to a 
rate per unit concentration of the components involved). 
133 
Bibliography 
[AB04) S. S. Andrews and D. Bray. Stochastic simulation of chemical reactions with 
spatial resolution and single molecule detail. Physical Biology, 1: 137-151, 
2004. 
[AJL+02] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter. Molec- 
ular Biology of the Cell. Garland Science, 4th edition, 2002. 
[And06] D. Anderson. Unpublished data, 2006. 
[ARM98] A. Arkin, J. Ross, and H. H. McAdams. Stochastic kinetic analysis of devel- 
opmental pathway bifurcation in phage lambda-infected escherichia coli cells. 
Genetics, 149(4): 1633-1648,1998. 
[Bae03] J. C. M. Baeten. Over 30 years of process algebra: Past, present and future. 
In L. Aceto, Z. Esik, W. J. Fokkink, and A. Ingölfsddttir, editors, Process 
Algebra: Open Problems and Future Directions, volume NS-03-3 of BRIGS 
Notes Series, pages 7-12.2003. 
[Bar93] J. Barnards. X-machine specification, verification and testing techniques. 
Master's thesis, Unversity of Sheffield, Department of Computer Science, 1993. 
[Bas00] J. B. Bassingthwaighte. Strategies for the physiome project. Annals of 
Biomedical Engineering, 28: 1043-1058,2000. 
[BB96] P. A. Baeuerle and D. Baltimore. NF-r,, B: ten years after. Cell, 87: 13-20, 
1996. 
[BBJ+03] K. Burrage, P. Burrage, S. Jeffrey, T. Pickett, It. Sidje, and T. Tian. A 
grid implementation of chemical kinetic simulation methods in genetic regu- 
lation. In Proceedings of the APAC03 Conference on Advanced Computing, 
Grid Applications and eResearch, 2003. 
134 
(BCT+04a) C. Baral, K. Chancellor, N. Tran, N. L. Tran, A. Joy, and M. Berens. A knowl- 
edge based approach for representing and reasoning about signaling networks. 
Bioinformatics, 20(Supplement 1): 115-122,2004. 
[BCT+04b] C. Baral, K. Chancellor, N. Tran, N. L. Tran, A. Joy, and M. Berens. A knowl- 
edge based approach for representing and reasoning about signaling networks. 
Bioinformatics, 20: i15-i22,2004. 
[Bed99) M. A. Bedau. Can unrealistic computer models illuminate theoretical biol- 
ogy? In 1999 Genetic and Evolutionary Computation Conference Workshop 
Program, pages 20-23,1999. 
[Ber93] H. C. Berg. Random Walks in Biology. Princeton University Press, 1993. 
[Bha03a] U. S. Bhalla. Models of cell signaling pathways. Current Opinions in Genetics 
and Development, 14: 375-381,2003. 
[Bha03b] U. S. Bhalla. Understanding complex signaling networks through models and 
metaphors. Progress in Biophysics and Molecular Biology, 81(1): 45-65,2003. 
[BHC+99] T. Balanescu, M. Holcombe, A. J. Cowling, H. Gheorgescu, M. Georghe, and 
C. Vertan. Communicating stream X-machines systems are no more than 
X-machines. Journal of Universal Computer Science, 5: 494-507,1999. 
[BR93] D. Brown and P Rothery. Models in Biology: Mathematics, Statistics and 
Computing. Wiley, 1993. 
[Bra01J D. Bray. Cell Movements: From Molecules to Motility. Garland Publishing, 
2nd edition, 2001. 
[Bra03] D. Bray. Molecular networks: the top-down view. Science, 301: 1864-1865, 
2003. 
[BT03] K. Burrage and T. Tian. Poisson runge-kutta methods for chemical reaction 
systems. In Proceedings of the Hong Kong Conference on Scientific Comput- 
ing, 2003. 
[BWK+05] D. Barken, C. J. Wang, J. Kearns, R. Cheong, A. Hoffmann, and 
A. Levchenko. Comment on `oscillations in NF-KB signaling control the dy- 
namics of gene expression'. Science, 308: 52a-52a, 2005. 
135 
[CCDQ99] F. Carlotti, R. Chapman, S. K. Dower, and E. E. Qwarnstrom. Activation 
of Nuclear Factor KB in single living cells. Journal of Biological Chemistry, 
274(53): 37941-37949,1999. 
[CDPT03] M. Curti, P. Degano, C. Priami, and Baldari C. T. Causal pi-calculus for 
biochemical modelling. CMSB'03,2602: 21-33,2003. 
[CDQ01] F. Carlotti, S. K. Dower, and E. E. Qwarnstrom. Dynamic shuttling of Nuclear 
Factor icB between the nucleus and cytoplasm as a consequence of inhibitor 
dissociation. Journal of Biological Chemistry, 275(52): 41028-41034,2001. 
[CGH] M. Calder, S. Gilmore, and J. Hilfston. Modelling the influence of RKIP on 
the ERK signalling pathway using the stochastic process algebra PEPA. 
[CGP99] E. Clark, 0. Grumberg, and D. Peled. Model Checking. The MIT Press, 1999. 
[CKL+97] P. Crepieux, H. Kwon, N. Leclerc, W. Spencer, S. Richard, and J. Hiscott. 
I, Ba physically interacts with a cytoskeleton-associated protein through its 
signal response domain. Journal of Physical Chemistry, 17(12): 7375-7385, 
1997. 
[CKTC+01J C. J. Caunt, E. Kiss-Toth, F. Carlotti, R. Chapman, and E. E. Qwarnstrom. 
Ras controls Tumor necrosis factor Receptor-Associated Factor (TRAF)6- 
dependent induction of Nuclear Factor-kB. Journal of Biological Chemistry, 
276(9): 6280-6288,2001. 
(CLB98) J. W. Christman, L. H. Lancaster, and T. S. Blackwell. Nuclear factor rcB: a 
pivotal role in the systemic inflammatory response syndrome and new target 
for therapy. Intensive Care Medicine, 24(11): 1131-1138,1998. 
[Cra75] J. Crank. The mathematics of diffusion. Oxford University Press, 2nd edition, 
1975. 
(CSH06] S. Coakley, R. Smallwood, and M. Holcombe. Using X-machines as a for- 
mal basis for describing agents in agent-based modelling. In Agent Directed 
Simulation 2006,2006. 
[CVGO] M. Calder, V. Vyshemirsky, D. Gilbert, and R. Orton. Analysis of signalling 
pathways using the PRISM model checker. 
136 
[CW03] K. H. Cho and 0. Wolkenhauer. Analysis and modelling of signal transduction 
pathways in systems biology. Biochemical Society Transactions, 31: 1503-1509, 
2003. 
[DS92] P. Doucet and P. B. Sloep. Mathematical Modelling in the Life Sciences. Ellis 
Norwood, 1992. 
[EI04] N. J. Eungdamrong and R. Iyengar. Modeling cell signaling networks. Biology 
of the Cell, 96: 355-362,2004. 
[EL00] M. B. Elowitz and S. Leibler. A synthetic oscillatory network of transcriptional 
regulators. Nature, 403: 335-338,2000. 
[E1e03] G. Eleftherakis. Formal verification of X-machine models: towards formal 
development of computer-based systems. PhD thesis, Unversity of Sheffield, 
Department of Computer Science, 2003. 
[ELSS02] M. B Elowitz, A. J. Levine, E. D. Siggia, and P. S. Swain. Stochastic gene 
expression in a single cell. Science, 297: 1183-1186,2002. 
[GCC+03] P. P. Gonzalez, M. Cardenas, D. Camacho, A. Franyuti, 0. Rosas, and 
J. Lagünez-Otero. Cellulat: an agent-based intracellular signalling model. 
Journal of Cell Science, 68: 171-185,2003. 
[Gi177} D. T. Gillespie. Exact stochastic simulation of coupled chemical reactions. 
Journal of Physical Chemistry, $1(25): 2340-2361,1977. 
[GP98] P. J. E. Goss and J. Peccoud. Quantitative modeling of stochastic systems in 
molecular biology by using stochastic petri nets. Proceedings of the National 
Academy of Sciences USA, 95: 6750-6755,1998. 
(Gut9l] H. Gutowitz. Cellular Automata: Theory and Experiment. The MIT Press, 
1991. 
[Han97] J. T. Hancock. Cell Signalling. Pearson Education Limited, 1997. 
[HB03J P. Hunter and T. K. Borg. Integration from proteins to organs: the physiome 
project. Nature Reviews Molecular Cell Biology, 4: 237-243,2003. 
137 
[HKV01) M. Heiner, I. Koch, and K. Voss. Analysis and simulation of steady states 
in metabolic pathways with petri nets. In CPN 01 - Third Workshop and 
Tutorial on Practical Use of Coloured Petri Nets and the CPN Tools, pages 
15-34,2001. 
[HLSB021 A. Hoffmann, A. Levchenko, M. L. Scott, and D. Baltimore. The I, B-NF-rKB 
signaling module: temporal control and selective gene activation. Science, 
298(5596): 1241-1245,2002. 
[HN63] A. E. Hall and D. Noble. Transient responses of purkinje fibres to non-uniform 
currents. Nature, 199: 1294-1295,1963. 
[HP96] C. H. Heldin and M. Purton, editors. Signal Transduction. Chapman and 
Hall, 1996. 
[HRN02] P. Hunter, P. Robbins, and D. Noble. The IUPS human physiome project. 
European Journal of Physiology, 445: 1-9,2002. 
[HS98] R. Heinrich and S. Schuster. The modelling of metabolic systems: structure, 
control and optimality. Biosystems, 47: 61-77,1998. 
[JD83] D. S. Jones and Sleeman B. D. Differential Equations and Mathematical 
Biology. George Allen and Unwin, 1983. 
[JHR04a) D. Jackson, M. Holcombe, and F. Ratnieks. Coupled computational sim- 
ulation and empirical research into the foraging system of Pharaoh's ant 
(monomorium pharaonis). Biosystems, 76: 101-112,2004. 
[JHR04b] D. Jackson, M. Holcombe, and F. Ratnieks. 'Rail geometry gives polarity to 
ant foraging networks. Nature, 432: 907-909,2004. 
[KG95] E. B. Kopp and S. Ghosh. NF-, B and rel proteins in innate immunity. Ad- 
vances in Immunology, 58: 1-27,1995. 
[Kit02a] H. Kitano. Computational systems biology. Nature, 420: 206-210,2002. 
[Kit02b] H. Kitano. Systems biology: A brief overview. Science, 295: 1662-1664,2002. 
[KOTSO4] A. Katsumi, A. W. Orr, E. Tzima, and M. A. Schwarz. Integrins in mechan- 
otransduction. Journal of Biological Chemistry, 279(13): 12001-12004,2004. 
138 
[LAB05] K. Lipkow, S. S. Andrews, and D. Bray. Simulated diffusion of phosphorylated 
CheY through the cytoplasm of Escherichia coli. Journal of Bacteriology, 
187: 45-53,2005. 
[LBZ+00] H. Lodish, A. Berk, S. L. Zipursky, P. Matsudaira, D. Baltimore, and J. Dar- 
nell. Molecular Cell Biology. W. H. Freeman and Company, 4th edition, 
2000. 
[Liu05] E. T. Liu. Integrative biology and systems biology. Molecular Systems Biology, 
1: E1,2005. 
[LPB+04] T. Lipniacki, P. Paszek, A. R. Brasier, B. Luxon, and M. Kimmel. Mathe- 
matical model of NF-kB regulatory module. Journal of Theoretical Biology, 
228(2): 195-295,2004. 
[LPB+06] T. Lipniacki, P. Paszek, A. R. Brasier, B. A. Luxon, and M. Kimmel. Stochas- 
tic regulation in early immune response. Biophysical Journal, 90: 725-742, 
2006. 
[MA97] H. H. McAdams and A. Arkin. Stochastic mechanisms in gene expression. 
Proc Nati Acad Sci USA, 94(3): 814-819,1997. 
[Mi199] R. Milner. Communicating and Mobile Systems: The ir-Calculus. Cambridge 
University Press, 1999. 
[MK98] P. Mendes and D. B. Kell. Non-linear optimization of biochemical pathways: 
applications to metabolic engineering and parameter estimation. l3ioinfor- 
matics, 14(10): 869-883,1998. 
[MN04) M. N. Moore and D. Noble. Editorial: computational modelling of cell and 
tissue processes and function. Journal of Molecular Histology, 35: 655-658, 
2004. 
[Mon03) N. A. M. Monk. Oscillatory expression of hest, p53, and NF-,. B driven by 
transcriptional time delays. Current Biology, 13(16): 1409-1413,2003. 
[MoyO5] P. N. Moynagh. The NF-icB pathway. Journal of Cell Science, 118: 4389-4392, 
2005. 
139 
[MSSL02] I. I. Moraru, J. C. Schaff, B. M. Slepchenko, and L. M. Low. The virtual cell: 
an integrated modeling environment for experimental and computational cell 
biology. Ann. NY Acad. Sci., 971: 595-596,2002. 
[Ne104) P. Nelson. Biological Physics. W. H. Freeman and Company, 2004. 
(NHS+05) D. E. Nelson, C. A. Horton, V. See, J. R. Johnson, G. Nelson, D. G. Spiller, 
D. B. Kell, and M. R. H. White. Response to comment on `oscillations in NF- 
KB signaling control the dynamics of gene expression'. Science, 308: 52b-52b, 
2005. 
[NIE+04] D. E. Nelson, A. E. C. Ihekwaba, M. Elliott, J. R. Johnson, C. A. Gibney, B. E. 
Foreman, G. Nelson, V. See, C. A. Horton, D. G. Spiller, S. W. Edwards, H. P. 
McDowell, J. F. Unitt, E. Sullivan, R. Grimley, N. Benson, D. Broomhead, 
D. B. Kell, and M. R. H. White. Oscillations in NF-KB signalling control the 
dynamics of gene expression. Science, 306: 704-708,2004. 
[Nob02] D. Noble. The rise of computational biology. Nature Reviews Molecular Cell 
Biology, 3: 460-463,2002. 
(O'N05] L. A. J. O'Neill. Immunity's early-warning system. Scientific American, pages 
38-45, January 2005. 
[Pa106] I. Palmer. Unpublished data, 2006. 
[PHPSO5) J. A. Papin, T. Hunter, B. 0. Palsson, and S. Subramaniam. Reconstruction 
of cellular signalling networks and analysis of their properties. Nature Reviews 
Molecular Cell Biology, 6(2): 99-111,2005. 
[PHS+06] M. Pogson, M. Holcombe, R. Smallwood, D. Anderson, and E. Qwarnstrom. 
Introducing spatial information into predictive of-rcb modelling-an agent- 
based approach. in preparation, 2006. 
[PS95] M. J. Pilling and P. W. Seakins. Reaction Kinetics. Oxford University Press, 
1995. 
[PS05] S. J. Plimpton and A. Slepoy. Microbial cell modeling via reacting diffusive 
particles. Journal of Physics: Conference Series, 16: 305-309,2005. 
140 
[PSQH06] M. Pogson, R. Smallwood, E. Qwarnstrom, and M. Holcombe. Formal agent- 
based modelling of intracellular chemical interactions. Biosystems, 85: 37-45, 
2006. 
[QMPD91] E. E. Qwarnstrom, S. A. MacFarlane, R. C. Page, and S. K. Dower. Inter- 
leukin 10 induces rapid phosphorylation and redistribution of talin: A possible 
mechanism for modulation of fibroblast focal adhesion. Proceedings of the Na- 
tional Academy of Sciences of the United States of America, 88(4): 1232-1236, 
1991. 
[QOT+94] E. E. Qwarnstrom, C. 0. Ostberg, G. L. Turk, C. A. Richardson, and K. Bom- 
sztyk. Fibronectin attachment activates the of-nb p50/p65 heterodimer 
in fibroblasts and smooth muscle cells. Journal of Biological Chemistry, 
269(9): 30765-30768,1994. 
[Qwa03) E. Qwarnstrom. Private communication, 2003. 
[RBW+90] D. Ron, A. R. Brasier, K. A. Wright, J. E. Tate, and J. F. Habener. An 
inducible 50-kilodalton of kappa b-like protein and a constitutive protein both 
bind the acute-phase response element of the angiotensinogen gene. Molecular 
and Cellular Biology, 10(3): 1023-1032,1990. 
[Ris96] H. Risken. The Fokker-Planck equation: methods of solutions and applica- 
tions. Springer, 1996. 
[RJHR05] E. J. H. Robinson, D. E. Jackson, M. Holcombe, and F. L. W. Ratnicks. Insect 
communication: 'no entry' signal in ant foraging. Nature, 438: 442,2005. 
[RSS01] A. Regev, W. Silverman, and E. Shapiro. Representation and simulation of 
biochemical processes using the pi-calculus process algebra. In Proceedings 
of the Pacific Symposium of Biocomputing 2001 (PSB2001), pages 459-470, 
2001. 
(SB86] R. Sen and D. Baltimore. Inducibility of rc immunoglobulin enhancer-binding 
protein NF-KB by a posttranslational mechanism. Cell, 47: 921-928,1986. 
[SB01) J. R. Stiles and T. M. Bartol. Monte carlo methods for simulating realistic 
synaptic microphysiology using mcell. In E. De Schutter, editor, Compu- 
141 
tational neuroscience: realistic modeling for experimentalists, pages 87-127. 
2001. 
[ScaO6] S. Scarle. Private communication, 2006. 
[SFL+93] M. L. Scott, T. Fujita, H. C. Liou, G. P. Nolan, and D. Baltimore. The 
p65 subunit of NF-nB regulates IKB by two distinct mechanisms. Genes and 
Development, 7(7): 1266-1276,1993. 
[SHWO4] R. H. Smallwood, W. M. L. Holcombe, and D. C. Walker. Development 
and validation of computational models of cellular interaction. Journal of 
Molecular Histology, 35: 659-665,2004. 
[TF01] P. P. Tak and G. S. Firestein. NF-, B: a key role in inflammatory diseases. 
Journal of Clinical Investigation, 107(1): 7-11,2001. 
[TM87] T. Toffoli and N. Margolus. Cellular Automata Machines: A New Environ- 
ment for Modelling. The MIT Press, 1987. 
[TRRG02] R. Taussig, R. Ranganathan, E. M. Ross, and A. G. Gilman. Overview of the 
alliance for cellular signalling. Nature, 420: 703-706,2002. 
[VAB04] S. J. Vayttaden, S. M. Ajay, and U. S. Bhalla. A spectrum of models of 
signaling pathways. Chembiochem, 5(10): 1365-1374,2004. 
[VdVP96] W. Van de Velde and J. W. Perram, editors. Agents Breaking Away. Springer, 
1996. 
[vZRtW05] J. S. van Zon and P. Rein ten Wolde. Simulating biochemical networks at 
the particle level and in time and space: Green's function reaction dynamics. 
Physical Review Letters, 94(12): 1281031-4,2005. 
[Wa106] D. C. Walker. Private communication, 2006. 
[WBHO5] S. L. Werner, D. Barken, and A. Hoffmann. Stimulus specificity of gene 
expression programs determined by temporal control of ikk activity. Science, 
309: 1857-1861,2005. 
[Wei02a] J. R. Weimar. Cellular automata approaches to enzymatic reaction networks. 
In S. Bandini, B. Chopard, and M. Tomassini, editors, Cellular Automata 
142 
(Fifth International Conference on Cellular Automata for Research and In- 
dustry ACRI), pages 294-303. Springer-Verlag, 2002. 
[Wei02b] J. R. Weimar. Three-dimensional cellular automata for reaction-diffusion sys- 
tems. Fundamenta Informaticae, 2: 275-282,2002. 
[WHW+04] D. C. Walker, G. Hill, S. M. Wood, R. H. Smallwood, and J. Southgate. 
Agent-based computational modelling of wounded epithelial cell monolayers. 
IEEE Transactions Nanobioscience, 3: 153-163,2004. 
[Wi188] J. Williams. Biochemistry. Gower Medical Publishing, 1988. 
[WMG99] K. K. Wary, A. Mariotti, and F. G. Giancotti. Specificity of integrin signalling. 
In J. L. Guan, editor, Signalling Through Cell Adhesion Molecules, pages 101- 
113. CRC Press LLC, 1999. 
[W0005] S. Wood. Private communication, 2005. 
[WSH+04] D. C. Walker, J. S. Southgate, G. Hill, M. Holcombe, D. R. Hose, S. M. 
Wood, S. MacNeil, and R. H. Smallwood. The Epitheliome: modelling the 
social behaviour of cells. Biosystems, 76: 89-100,2004. 
[Yan03] L. Yang. Unpublished data, 2003. 
[YCQ01] L. Yang, H. Chen, and E. Qwarnstrom. Degradation of InBa is limited by a 
postphosphorylation/ubiquitination event. Biochemical and Biophysical Re- 
search Communications, 285(3): 603-608,2001. 
[YG01] Y. Yamamoto and R. B. Gaynor. Therapeutic potential of inhibition of the 
NF-nB pathway in the treatment of inflammation and cancer. Journal of 
Clinical Investigation, 107(2): 135-142,2001. 
[YRQ03] L. Yang, K. Ross, and E. E. Qwarnstrom. RelA control of IKBa phosphory- 
lation: a positive feedback loop for high affinity NF-KB complexes. Journal 
of Biological Chemistry, 278(33): 30881-30888,2003. 
[YYGK02] T. Yamanda, Y. Yamanishi, S. Goto, and M. Kanehisa. Extraction of modules 
from the metabolic pathways with phylogenetic profile. Genome Informatics, 
13: 353-354,2002. 
[Zha051 F. Zhao. Private communication, 2005. 
143 
